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1. PUBLIC HEALTH STATEMENT 
 
 
This Statement was prepared to give you information about di-n-octylphthalate and to 
emphasize the human health effects that may result from exposure to it. The Environmental 
Protection Agency (EPA) has identified 1,416 hazardous waste sites as the most serious in the 
nation. These sites make up the National Priorities List (NPL) and are the sites targeted for 
long-term federal cleanup activities. Di-n-octylphthalate has been found in at least 300 of 
the sites on the NPL. However, the number of NPL sites evaluated for di-n-octylphthalate is 
not known. As EPA evaluates more sites, the number of sites at which di-n-octylphthalate is 
found may increase. This information is important because exposure to di-n-octylphthalate 
may cause harmful health effects and because these sites are potential or actual sources of 
human exposure to di-n-octylphthalate. 
 
When a substance is released from a large area, such as an industrial plant, or from a 
container, such as a drum or bottle, it enters the environment. This release does not always 
lead to exposure. You can be exposed to a substance only when you come in contact with it. 
You may be exposed by breathing, eating, or drinking substances containing the substance or 
by skin contact with it. 
 
If you are exposed to a substance such as di-n-octylphthalate, many factors will determine 
whether harmful health effects will occur and what the type and severity of those health 
effects will be. These factors include the dose (how much), the duration (how long), the 
route or pathway by which you are exposed (breathing, eating, drinking, or skin contact), the 
other chemicals to which you are exposed, and your individual characteristics such as age, 
gender, nutritional status, family traits, life-style, and state of health.  
 
1 .1 WHAT IS DI-n-OCTYLPHTHALATE? 
 
Di-n-octylphthalate, also known as dioctyl phthalate, is a colorless, odorless, oily liquid. It 
does not evaporate easily. There is no evidence that di-n-octylphthalate occurs naturally in 
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the environment. Di-n-octylphthalate is manufactured for many uses. It is commonly used as 
a plasticizer (a substance added to plastics to keep them soft or more flexible). These plastics 
are found in products such as carpetback coating, packaging films, medical tubing and blood 
storage bags, floor tile, wire, cables, and adhesives. Di-n-octylphthalate is also used in 
cosmetics and pesticides. For more information on the chemical and physical properties of 
di-n-octylphthalate, see Chapter 3. For more information on its production and use, see 
Chapter 4. 
 
1.2  WHAT HAPPENS TO DI-n-OCTYLPHTHALATE WHEN IT ENTERS THE 
       ENVIRONMENT? 
 
Di-n-octylphthalate may enter the environment in industrial waste waters, air emissions, and 
solid wastes from manufacturing and processing operations, from evaporation of the 
compound from plastics, from the burning of plastic products, and by leaking from plastics in 
landfills into soil or water, including groundwater. Di-n-octylphthalate is expected to stick 
tightly to soil, sediment, and dust particles once it is released to the environment. If released 
to the atmosphere, the compound may be deposited on the ground or to surface water in rain 
or dust particles. Small amounts of the compound can build up in animals that live in water, 
such as fish and oysters. The compound breaks down into other products mainly by the 
action of microorganisms. Additional ways di-n-octylphthalate is transformed into other 
substances include reaction with sunlight and other chemicals present in the atmosphere, 
reaction with water, and breakdown of the compound in surface waters by sunlight. For 
further information on what happens to di-n-octylphthalate when it enters the environment, 
see Chapters 4 and 5. 
 
1.3 HOW MIGHT I BE EXPOSED TO DI-n-OCTYLPHTHALATE?  
 
You may be exposed to di-n-octylphthalate by eating foods contaminated with any of the 
compound that has leaked from plastic containers, by eating certain foods, such as fish, that 
have built up high levels of the compound, and by drinking contaminated water. You may 
also be exposed to di-n-octylphthalate during medical treatments such as blood transfusions 
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and dialysis that use equipment made of plastics containing di-n-octylphthalate. In addition, 
if you live near a hazardous waste site or an industrial manufacturing or processing facility, 
you may be exposed through contact with air, water, or soil that may have been contaminated 
around these sites. Little information is available about the concentrations of di-noctylphthalate 
in air, water, or soil. The compound has been measured at 0.06-0.94 parts di-n-octylphthalate per trillion 
parts of air (ppt), in rain at 2.6-20 ppt, in river water at l-310 ppt, and in sediment at less than 5-25,000 ppt. 
 
Workers in the chemicals and plastics industries may also be exposed to di-n-octylphthalate. 
The National Occupational Exposure Survey estimated that 10,393 individuals were exposed 
to the compound in the workplace in 1980. For further information on how you can be 
exposed to di-n-octylphthalate, see Chapter 5. 
 
 
1.4 HOW CAN DI-n-OCTYLPHTHALATE ENTER AND LEAVE MY BODY? 
 
Di-n-octylphthalate can enter your body when you drink water or eat food containing it. We 
do not know if di-n-octylphthalate enters your body when you breathe air containing it or 
when it comes in contact with your skin. It is possible that exposure could occur near 
hazardous waste sites, at manufacturing facilities, or through the use of consumer products 
containing the substance. We do not know how much you will absorb if you eat or drink it. 
Di-n-octylphthalate can also enter your body during medical treatment through the use of 
plastic tubing or storage bags contaminated with di-n-octylphthalate. Once it enters your 
body, it breaks down into other chemicals and the health effects of some of these chemicals 
are not well understood. Di-n-octylphthalate and its breakdown products will leave your body 
mostly in your urine, but we do not know how quickly that happens. We do not know if the 
compound or its breakdown products will remain in the tissues. For more information on 
how di-n-octylphthalate can enter and leave your body, see Chapter 2. 
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1.5 HOW CAN DI-n-OCTYLPHTHALATE AFFECT MY HEALTH? 
 
No information is available regarding the possible human health effects caused by di-n- 
octylphthalate if you breathe, eat, drink, or have skin contact with it. Furthermore, there is 
no information on the effects of breathing di-n-octylphthalate in laboratory animals. Di-n- 
octylphthalate has caused death in some rats and mice given very high doses by mouth. 
Mildly harmful effects have been seen in the livers of some rats and mice given very high 
doses of di-n-octylphthalate by mouth for short or intermediate durations of time. Brief oral 
exposures to lower doses of di-n-octylphthalate generally caused no harmful effects. 
 
We have no information on the health effects of di-n-octylphthalate when applied to the skin 
of humans for long periods of time. Di-n-octylphthalate can be mildly irritating when 
applied to the skin of animals. It can also be slightly irritating when put directly into the 
eyes of animals. For more information on the health effects of di-n-octylphthalate, please 
refer to Chapter 2. 
 
We do not know if di-n-octylphthalate causes cancer in humans or animals. Unlike other 
phthalates such as di(2-ethylhexyl)phthalate, di-n-octylphthalate does not appear to affect the 
ability of male animals to father offspring [see ATSDR toxicological profile for di(2- 
ethylhexyl)phthalate for more information on this chemical]. Some birth defects occurred in 
newborn rats whose mothers received high doses (approximately 5 grams per kilogram of 
body weight [5 g/kg]) of di-n-octylphthalate by injection during pregnancy. However, 
humans are not exposed to di-n-octylphthalate this way, and no harmful effects on developing 
fetuses were seen when mice were given this chemical by mouth. 
 
Di-n-octylphthalate has not been classified for carcinogenic effects by the Department of 
Health and Human Services, the International Agency for Research on Cancer, or the EPA. 
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1.6 IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN 
      EXPOSED TO DI-n-OCTYLPHTHALATE? 
 
Di-n-octylphthalate and its principal breakdown products can be measured in urine, blood, ant 
tissues. However, the information available on these tests is so limited that it is not possible 
to know if they are specific for di-n-octylphthalate, if they can be used to determine how 
much you were exposed to, if they can predict whether harmful health effects will occur, or 
how long the test is useful after exposure occurs. These tests are not available in doctors’ 
offices. See Chapters 2 and 6 for more information 
 
1.7 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE      
       TO PROTECT HUMAN HEALTH? 
 
The government has developed guidelines for di-n-octylphthalate. These are designed to 
protect the public from the possible harmful health effects of the chemical. However, EPA 
has recently determined that there is not enough evidence to say that di-n-octylphthalate 
definitely causes harmful effects in humans or to the environment. See Chapter 7 for more 
information on regulations and guidelines for di-n-octylphthalate. 
 
1.8 WHERE CAN I GET MORE INFORMATION? 
 
If you have any more questions or concerns, please contact your community or state health or 
environmental quality department or: 
 
Agency for Toxic Substances and Disease Registry 
Division of Toxicology 
1600 Clifton Road NE, E-29 
Atlanta, Georgia 30333 
(404) 639-6000 
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This agency can also provide you with information on the location of occupational and 
environmental health clinics. These clinics specialize in the recognition, evaluation, and 
treatment of illness resulting from exposure to hazardous substances. 
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The primary purpose of this chapter is to provide public health officials, physicians, toxicologists, and 
other interested individuals and groups with an overall perspective on the toxicology of di-n-
octylphthalate. It contains descriptions and evaluations of toxicological studies and epidemiological 
investigations and provides conclusions, where possible, on the relevance of toxicity and toxicokinetic 
data to public health. 
 
A glossary and list of acronyms, abbreviations, and symbols can be found at the end of this profile. 
 
2.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE 
 
To help public health professionals and others address the needs of persons living or working near 
hazardous waste sites, the information in this section is organized first by route of exposure - 
inhalation, oral, and dermal; and then by health effect - death, systemic, immunological, neurological, 
reproductive, developmental, genotoxic, and carcinogenic effects. These data are discussed in terms of 
three exposure periods - acute (14 days or less), intermediate (15-364 days), and chronic (365 days 
or more). 
 
Levels of significant exposure for each route and duration are presented in tables and illustrated in 
figures. The points in the figures showing no-observed-adverse-effect levels (NOAELs) or lowest-
observed-adverse-effect levels (LOAELs) reflect the actual doses (levels of exposure) used in the 
studies. LOAELs have been classified into “less serious” or “serious” effects. “Serious” effects are 
those that evoke failure in a biological system and can lead to morbidity or mortality (e.g., acute 
respiratory distress or death). “Less serious” effects are those that are not expected to cause significant 
dysfunction or death, or those whose significance to the organism is not entirely clear. ATSDR 
acknowledges that a considerable amount of judgment may be required in establishing whether an end 
point should be classified as a NOAEL, “less serious” LOAEL, or “serious” LOAEL, and that in some 
cases, there will be insufficient data to decide whether the effect is indicative of significant 
dysfunction. However, the Agency has established guidelines and policies that are used to classify 
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these end points. ATSDR believes that there is sufficient merit in this approach to warrant an attempt 
at distinguishing between “less serious” and “serious” effects. The distinction between “less serious” 
effects and “serious” effects is considered to be important because it helps the users of the profiles to 
identify levels of exposure at which major health effects start to appear. LOAELs or NOAELs should 
also help in determining whether or not the effects vary with dose and/or duration, and place into 
perspective the possible significance of these effects to human health. 
 
The significance of the exposure levels shown in the Levels of Significant Exposure (LSE) tables and 
figures may differ depending on the user’s perspective. Public health officials and others concerned 
with appropriate actions to take at hazardous waste sites may want information on levels of exposure 
associated with more subtle effects in humans or animals or exposure levels below which no adverse 
effects have been observed. Estimates of levels posing minimal risk to humans (Minimal Risk Levels 
or MRLs) may be of interest to health professionals and citizens alike. 
 
Estimates of exposure levels posing minimal risk to humans (Minimal Risk Levels or MRLs) have 
been made for di-n-octylphthalate. An MRL is defined as an estimate of daily human exposure to a 
substance that is likely to be without an appreciable risk of adverse effects (noncarcinogenic) over a 
specified duration of exposure. MRLs are derived when reliable and sufficient data exist to identify 
the target organ(s) of effect or the most sensitive health effect(s) for a specific duration within a given 
route of exposure. MRLs are based on noncancerous health effects only and do not consider 
carcinogenic effects. MRLs can be derived for acute, intermediate, and chronic duration exposures for 
inhalation and oral routes. Appropriate methodology does not exist to develop MRLs for dermal 
exposure. 
 
Although methods have been established to derive these levels (Barnes and Dourson 1988; EPA 
1990a), uncertainties are associated with these techniques. Furthermore, ATSDR acknowledges 
additional uncertainties inherent in the application of the procedures to derive less than lifetime MRLs. 
As an example, acute inhalation MRLs may not be protective for health effects that are delayed in 
development or are acquired following repeated acute insults, such as hypersensitivity reactions, 
asthma, or chronic bronchitis. As these kinds of health effects data become available and methods to 
assess levels of significant human exposure improve, these MRLs will be revised. 
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A User’s Guide has been provided at the end of this profile (see APPENDIX B). This guide should aid 
in the interpretation of the tables and figures for Levels of Significant Exposure and the MRLs. 
 
The toxicity information presented in this chapter focuses on studies that have identified with 
reasonable certainty that their test material is di-n-octylphthalate or its monoester metabolite, mono-n-
octylphthalate. Unfortunately, use of the nonspecific term “di-octylphthalate” has contributed to 
significant confusion and misinformation in the technical and governmental literature with respect to 
di-n-octylphthalate and its much more common isomer, di(2-ethylhexyl)phthalate. Although frequently 
interpreted as referring to di-n-octylphthalate, it is apparent that in almost all cases “di-octylphthalate” 
and “DOP” have in fact been used as synonyms for di(2-ethylhexyl)phthalate. Throughout this chapter 
whenever possible, an assessment of the level of certainty that the test compound was di-noctylphthalate 
will be made. 
 
2.2.1 inhalation Exposure 
 
No studies were located regarding the following health effects in humans or animals after inhalation 
exposure to di-n-octylphthalate: 
 
2.2.1.1 Death 
2.2.1.2 Systemic Effects 
2.2.1.3 Immunological and Lymphoreticular Effects 
2.2.1.4 Neurological Effects 
2.2.1.5 Reproductive Effects 
2.2.1.6 Developmental Effects 
2.2.1.7 Genotoxic Effects 
 
Genotoxicity studies are discussed in Section 2.5. 
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No studies were located regarding cancer in humans or animals after inhalation exposure to di-n-
octylphthalate. 
 
2.2.2 Oral Exposure 
 
2.2.2.1 Death 
No studies were located regarding death in humans after oral exposure to di-n-octylphthalate. 
 
In animals, the reported oral LD50 values are 53,700 mg/kg body weight for male albino rats (Dogra 
et al. 1987), 13,000 mg/kg for Swiss albino mice (Dogra et al. 1989), and >12,800 mg/kg for mice 
(Eastman Kodak Company 1978). Dosing was by gavage in these studies. No additional studies were 
located regarding death in animals after oral exposure to di-n-octylphthalate. 
 
LOAEL values from each reliable study for death in each species and duration category are recorded 
in Table 2-l and plotted in Figure 2- 1. 
 
2.2.2.2 Systemic Effects 
 
No studies were located regarding respiratory, cardiovascular, musculoskeletal, dermal, or ocular 
effects in humans or animals after oral exposure to di-n-octylphthalate. The systemic effects observed 
after oral exposure are discussed below. The highest NOAEL values and all LOAEL values from each 
reliable study for observed systemic effects in each species and duration category are recorded in 
Table 2-l and plotted in Figure 2-1. 
 
Gastrointestinal Effects. No studies were located regarding gastrointestinal effects in.humans after oral 
exposure to di-n-octylphthalate. 
 
One study reported that feeding di-n-octylphthalate to groups of four male Wistar albino rats at 
average doses of 2,266 mg/kg/day for 3 days, 2,078 mg/kg/day for 10 days, or 1,096 mg/kg/day for 
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analytical data were reported, but it is reasonably certain that the test compound was di-n-octylphthalate 
(purity was reported to be 99.5%). 
 
Hematological Effects. No studies were located regarding hematological effects in humans after oral 
exposure to di-n-octylphthalate. 
 
One study in Sprague-Dawley rats (10/sex/group) reported that feeding di-n-octylphthalate at 
concentrations up to 5,000 ppm (350.1 or 402.9 mg/kg/day in males or females, respectively) for 
13 weeks did not affect hematological parameters (Poon et al. 1995). 
 
Hepatic Effects. No studies were located regarding hepatic effects in humans after oral exposure to di-n-
octylphthalate. 
 
Several studies were located that reported a variety of hepatic effects in rats and mice usually after 
large oral doses were administered for acute or intermediate durations. These include effects of di-n-
octylphthalate on liver appearance, structure, and function. 
 
Gross Appearance and Organ Mass. Upon dietary exposure of groups of four male Wistar albino rats 
to 1,906-2,266 mg/kg/day of di-n-octylphthalate for 3-21 days, livers were reported to be pale and 
greasy in appearance (Mann et al. 1985). When compared with control values, no change in liver 
weight was observed after 3 days of treatment, although small but significant (p < 0.01) increases in 
relative liver weight (liver weight as a percentage of body weight) were noted after 10 days (4.7% 
versus 4.0%, or a 19% change from control) and 21 days (4.1% versus 3.2%, or a 28% change from 
control) of treatment. Similarly, absolute (15%) or relative (16%) liver weights were increased 
significantly in 10 male Wistar rats after 7 days of dietary exposure to 1,000 mg/kg/day (Oishi and 
Hiraga 1980). Relative liver weight was significantly increased in 6 male Sprague-Dawley rats after 
14 days of exposure by gavage to 1,000 or 2,000 mg/kg/day (Lake et al. 1984, 1986). No changes in 
absolute or relative liver weights were noted after Sprague-Dawley rats (10/sex/group) were fed 
concentrations of up to 5,000 ppm (350.1 or 402.9 mg/kg/day in males and females, respectively) in 
the diet for 13 weeks (Poon et al. 1995). 
 
Male rats, initiated with a single intraperitoneal dose of the carcinogen diethylnitrosamine and then 
partially hepatectomized, did not experience any liver weight gain after 10 weeks of dietary exposure 
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to 500 mg/kg/day of di-n-octylphthalate (DeAngelo et al. 1986). When exposure was extended to
26 weeks, small increases in absolute liver weight that were not significant (p < 0.05) were observed
at di-n-octylphthalate doses of 250 mg/kg/day (2% increase) and 500 mg/kg/day (8% increase).
However, when combined with diminished body weight gains, relative liver weight gains were
increased by 5-16% when compared with control values (Carter et al. 1992). These results should be
considered independently of the other studies discussed because the animals were surgically altered
and chemically treated with diethylnitrosamine.
Dietary exposure for 85-105 days (including lactation during exposure of the dams) to
8,640 mg/kg/day of di-n-octylphthalate also induced significant (p < 0.05) absolute liver weight gains
in male and female CD-l mice (Heindel et al. 1989; Morrissey et al. 1989; NTP 1985). All three of
these papers reported the same study; the dose specified here is from the Morrissey et al. (1989)
report. A l-week dietary exposure to 1,000 mg/kg/day of mono-n-octylphthalate was also reported to
induce liver enlargement in seven male Wistar rats (Oishi and Hiraga 1982). Whether those modest
liver weight increases resulted primarily from hyperplasia or from hypertrophy is not clear. However,
the absence of increased hepatic mitotic activity in two of four rats after di-n-octylphthalate exposure
in the Mann et al. (1985) study noted above suggests that significant hyperplasia may not be a factor.
Morphology, Histopathology, and Biochemistry. Aside from the pale, greasy appearance noted above,
livers from male Wistar rats exposed for 3 days to 2,266 mg/kg/day of di-n-octylphthalate in the diet
displayed a loss of centrilobular glycogen (Mann et al. 1985). Proliferation and dilation of the smooth
endoplasmic reticulum accompanied by some loss of rough endoplasmic reticulum were noted, as were
shortened microvilli in some bile canaliculi. No significant changes were noted in parameters
associated with hepatic peroxisomal activity (cyanide-insensitive palmitoyl CoA oxidase, α-glycero-
phosphate dehydrogenase, and total or peroxisomal catalase activities), plasma membrane integrity
(plasma membrane 5’-nucleotidase activity), mitochondrial respiration (succinate dehydrogenase
activity), endoplasmic reticular function (glucose-6-phosphatase activity and level of cytochrome
P-450), or in the level of nonenzymic reductants. When exposure time was increased to 10 or 21 days
(average doses of 2,078 or 1,906 mg/kg/day di-n-octylphthalate, respectively), the centrilobular
reduction in glycogen became more severe and was associated with fat accumulation and some
necrosis. However, the almost total loss of liver glycogen that was observed when using similar doses
of di(2-ethylhexyl)phthalate did not occur. Lipid droplets were observed in hepatocytes, along with a
possible small increase in the number of peroxisomes; the endoplasmic reticulum morphology
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alterations remained apparent. Small but significant (p < 0.01 or 0.05) increases were found in
hepatic cyanide-insensitive palmitoyl CoA oxidase and peroxisomal catalase activities but not in
α-glycerophosphate dehydrogenase or total catalase activities. Significant reductions were noted in
5’-nucleotidase, succinate dehydrogenase, and glucose-6-phosphatase activities compared to the
controls. In contrast to di-n-octylphthalate treatment, similar doses of di(2-ethylhexyl)phthalate
resulted in a dark, enlarged liver, and an initial burst of mitosis was noted at day 3 in two out of four
rats. A lesser degree of early centrilobular glycogen loss was noted with di(ethylhexyl)phthalate, but
almost total liver glycogen loss occurred after 21 days along with periportal rather than centrilobular
fat accumulation, no centrilobular necrosis, pronounced peroxisome proliferation, greater smooth
endoplasmic reticulum proliferation, mitochondrial matrix changes, and larger reductions in
5’-nucleotidase, glucose-6-phosphatase, and nonenzymic reductant activities.
Sprague-Dawley rats (10/sex/group) fed 0, 5, 50, 500, or 5,000 ppm of di-n-octylphthalate in the diet,
corresponding to intakes of 0, 0.4, 3.5, 36.8, and 350.1 mg/kg/day (males) or 0, 0.4, 4.1, 40.8, and
402.9 mg/kg/day (females), for 13 weeks showed significant increases in hepatic ethoxyresorufin-O-
demethylase activities at the highest dose (Poon et al. 1995). There were histopathologic changes in
hepatic architecture noted at 5,000 ppm, however, which included a moderate degree of accentuation
of zonation in all animals of both sexes and mild-to-moderate perivenous cytoplasmic vacuolation in
9/10 males and 5/10 females (Poon et al. 1995). These effects were not observed at 500 ppm, which
represents the NOAEL. There was no visual increase in peroxisomes noted at any dose level and no
changes in activities of either amino-N-demethylase or aniline hydrolase.
Rats exposed to dietary concentrations of mono-n-octylphthalate equivalent to 1,000 mg/kg/day
exhibited a variety of significant alterations in serum lipid composition, reflecting a possible effect on
the hepatic metabolism of lipids (Oishi and Hiraga 1982). With respect to control values, serum
concentrations of phospholipids and nonesterified fatty acids were increased, while those of
triglycerides and total cholesterol were decreased. Levels of free cholesterol, lipoperoxides, and
1ecithin:cholesterol acyltransferase activity were not significantly affected. Mono-n-octylphthalate
exposure increased palmitic acid content while decreasing stearic acid content in serum phospholipid;
increased oleic acid content in serum phospholipid, cholesteryl ester, and triglyceride; decreased
linoleic acid content in serum triglyceride; and decreased arachidonic acid content in serum
phospholipid. Several other monophthalates were also evaluated, with mono-2-ethylhexylphthalate
being generally somewhat more potent than mono-n-octylphthalate. The compositional effects of
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mono-2-ethylhexylphthalate on serum cholesteryl ester were broader and more pronounced than those 
of mono-n-octylphthalate, while the reverse was true for serum triglyceride (mono-2- 
ethylhexylphthalate was without significant effect). Such effects could result in part from altered 
gastrointestinal digestion and absorption of dietary fat, but as suggested by the previously noted 
accumulation of fat in the liver (Mann et al. 1985), they may reflect altered hepatic metabolism of 
fatty acids and cholesterol. The toxicological significance of these alterations in lipid metabolism is 
not known. The study authors noted that the general trend of these serum lipid changes and the 
attendant increases in liver size are significantly similar to the effects observed after exposure to di(2- 
ethylhexyl)phthalate (see also ATSDR 1992), thus implicating the monoesters or subsequent 
metabolites, rather than the diesters, as the active compounds inducing these effects. 
 
Treating male Sprague-Dawley rats with di-n-octylphthalate (2,000 mg/kg/day) or mono-n-octylphthalate 
(750 and 1,000 mg/kg/day) by gavage for 14 days (5 rats/dose) did not induce hepatic 
peroxisome proliferation (Lake et al. 1984). Similar treatment with 1,000 mg/kg/day di-n-octylphthalate or 
715 mg/kg/day mono-n-octylphthalate did not significantly increase (cyanide-insensitive palmitoyl-CoA 
oxidase and heat-liable enoyl-CoA hydratase) or reduce (O-amino acid 
oxidase) hepatic enzyme activities associated with peroxisome proliferation (Lake et al. 1984, 1986). 
Both di-n-octylphthalate and mono-n-octylphthalate significantly reduced (p < 0.05) hepatic 
microsomal-7-ethoxyresorutin O-deethylase activity, and di-n-octylphthalate reduced 7-ethoxycoumarin 
O-deethylase activity, but neither di-n-octylphthalate nor mono-n-octylphthalate significantly affected 
other mixed function oxidase activities (ethylmorphine n-demethylase, lauric acid 11-and 
12-hydroxylases), microsomal cytochrome P-450 content, microsomal hemoprotein spectral properties, 
or sodium dodecyl sulfate-polyacrylamide gel electrophoresis profiles of hepatic whole homogenates 
and microsomes. Again, these results were substantially different from those obtained with doses of 
1,000 mg/kg di(2-ethylhexyl)phthalate and 500 mg/kg of the hypolipidemic drug clofibrate. 
 
Two additional rat studies designed to investigate the reproductive effects of di-n-octylphthalate 
exposure provide another observation on the hepatic effects of di-n-octylphthalate. Contrary to what is 
observed with di(2-ethylhexyl)phthalate, the concentration in liver of the essential element zinc was 
found not to be significantly reduced after 4 days of gavage exposure to 2,800 mg/kg/day of di-n-
octylphthalate (Foster et al. 1980), or 7 days of dietary exposure to 1,000 mg/kg/day of di-n-octylphthalate 
(Oishi and Hiraga 1980). 
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The only oral study located that evaluated the presence of hepatic effects in a species other than rats 
was a reproductive-developmental toxicity study conducted according to the NTP Continuous Breeding 
Protocol (Heindel et al. 1989; Morrissey et al. 1989; NTP 1985). F1 generation CD-l mice (offspring 
from the fifth litter of a treated F0 generation) were exposed via lactation to di-n-octylphthalate (from 
dams exposed to approximately 7,460 mg/kg/day) and then via feed after weaning until they were 
85-105 days old. The average di-n-octylphthalate dose over this period was calculated by the study 
authors to be 8,640 mg/kg/day. As might be expected from prior rat data, statistically significant 
increases in absolute liver weight (24%) were noted. The study authors reported that no gross 
morphological or histopathological alterations were observed in the treated livers. This is despite 
substantially higher doses and longer treatment times than were used in the rat studies and despite a 
fourfold lower acute oral LD50 reported for mice than for rats (Dogra et al. 1987, 1989). As has been 
noted for di(2-ethylhexyl)phthalate (ATSDR 1992), the degree and nature of hepatotoxicity resulting 
from exposure to di-n-octylphthalate may vary considerably with species and also with dosage 
procedures. Dogra et al. (1987, 1989) employed oral gavage with rats and mice, whereas the NTP 
study employed dietary feeding with mice. 
 
In summary, the liver appears to be a primary target organ for the toxic effects of acute- and 
intermediate-duration high-dose exposure to di-n-octylphthalate (and mono-n-octylphthalate), at least in 
the rat and mouse. Unlike its branched-chain isomer di(2-ethylhexyl)phthalate, di-n-octylphthalate 
presents a liver toxicity profile only weakly suggestive of the hypolipidemic peroxisome proliferators 
(e.g., clofibrate). Instead, the liver changes associated with exposure to di-n-octylphthalate are 
characterized by marked centrilobular accumulation of fat and loss of glycogen, accompanied by 
reduced glucose-6-phosphatase, cytoplasmic vacuolation, accentuation of zonation, and some 
centrilobular necrosis. However, although these effects have been noted in two studies (Mann et al. 
1985; Poon et al. 1995), they were not seen in a multigeneration study in mice by NTP (Heindel et al. 
1989; Morrissey et al. 1989; NTP 1985) or in other studies in rats (Lake et al. 1984, 1986; Oishi and 
Hiraga 1980). It should be mentioned here that di-n-octylphthalate has been shown to induce 




Renal Effects. No studies were located regarding renal effects in humans after oral exposure to di-n-
octylphthalate.
Few animal studies were located that report any observations on the renal toxicity of di-n-octylphthalate.
In a study examining the effects of di-n-octylphthalate on testicular function, rats that
had received 2,800 mg/kg/day by gavage for 4 days were observed to have a small (9%) but not
statistically significant reduction in kidney zinc concentration when compared with controls (Foster
et al. 1980). Total urinary excretion of zinc was reduced to 85% of controls, but again this was not
significant. When expressed as a percentage of zinc excretion on day 0 (i.e., prior to di-noctylphthalate
administration), the 4-day urinary excretion profile of zinc in the di-n-octylphthalate-treated
rats was virtually identical to that of controls. No effect on kidney weight was observed. In
contrast, these parameters were generally elevated after treatment with n-alkylphthalates that induced
testicular pathology (di-n-butylphthalate, di-n-pentylphthalate, and di-n-hexylphthalate; see
“Reproductive Effects,” below). These findings are supported by another study in rats in which dietary
exposure of male Wistar rats for 1 week to 1,000 mg/kg/day of di-n-octylphthalate did not affect the
concentration of zinc in the kidney (phthalic acid slightly increased it) nor significantly (p < 0.05)
reduce kidney weight as did di(2-ethylhexyl)phthalate (Oishi and Hiraga 1980). No gross pathological
changes were observed in the kidneys of male Wistar rats following 3-, 10-, or 21-day exposure to 2%
di-n-octylphthalate in the diet (2,266, 2,078, or 1,906 mg/kg/day, respectively) (Mann et al. 1985). No
effects on absolute or relative kidney weight were noted when Sprague-Dawley rats of both sexes were
fed di-n-octylphthalate for 13 weeks at concentrations up to 5,000 ppm (350.1 or 402.9 mg/kg/day in
males and females, respectively) (Poon et al. 1995).
One reproductive-developmental toxicity study in CD-l mice also examined the renal effects of di-n-
octylphthalate exposure (Heindel et al. 1989; Morrissey et al. 1989; NTP 1985). Following the NTP
Continuous Breeding Protocol, F1 mice taken from the last litter of treated F1 parental mice
(7,460 mg/kg/day for 105 days, including the mating period) were exposed for 85-105 days to an
average calculated di-n-octylphthalate dose of 8,640 mg/kg/day (first via lactation, then feed).
Although no gross morphological or histopathological changes in the kidney were noted, absolute
kidney weight was significantly (p < 0.05) elevated in female (1l%), but not male, mice.
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Despite the absence of data on organ function, these limited results suggest that acute or intermediate 
oral exposure to even very high doses of di-n-octylphthalate is not likely to result in substantial renal 
toxicity. 
 
Endocrine Effects. No studies were located regarding endocrine effects in humans after oral 
exposure to di-n-octylphthalate. 
 
There is some evidence in animals that suggests that oral administration of di-n-octylphthalate may 
affect the thyroid gland. Serum from four male Wistar rats that were fed di-n-octylphthalate at a 
concentration of 2% in the diet (approximately 2,000 mg/kg/day) in a previous study (Mann et al. 
1985) was reassayed (Hinton et al. 1986). After 3, 10, and 21 days of treatment, significant decreases 
in thyroxine (T4) levels were noted compared to the controls. T4 levels were 47%, 59%, and 76% of 
control values after 3, 10, and 21 days of treatment, respectively. No significant effects on 
triiodothyronine (T3) levels were noted compared to the controls (Hinton et al. 1986). In addition, 
marked ultrastructural changes were noted in the thyroids of these animals, including increases in the 
numbers and size of lysosomes, enlargement of the Golgi apparatus, and apparent damage to the 
mitochondria (Hinton et al. 1986). This study was limited, however, in that only one concentration 
was tested. 
 
Groups of 10 male and 10 female Sprague-Dawley rats that were administered di-n-octylphthalate in 
the diet for 13 weeks at concentrations of 0, 5, 50, 500 and 5,000 ppm, corresponding to intakes of 0, 
0.4, 3.5, 36.8, and 350.1 mg/kg/day (males) and 0, 0.4, 4.1, 40.8, and 402.9 mg/kg/day (females) 
showed reductions in the size of thyroid follicles and mild decreases in colloid density at 
5,000 ppm (Poon et al. 1995). Changes in these parameters was also noted at 500 ppm, but it is not 
whether this concentration represents a LOAEL, because statistical analysis of the data was not 
performed. 
 
Body Weight Effects. No studies were located regarding body weight effects in humans after oral 
exposure to di-n-octylphthalate. 
 
Data from various studies consistently indicate that acute or intermediate oral exposures to high doses 
(l,000-15,000 mg/kg/day) of di-n-octylphthalate do not adversely affect either body weight gain or 
food consumption in rats or mice (Carter et al. 1992; Heindel et al. 1989; Mann et al. 1985; Morrissey 
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et al. 1989; NTP 1985; Oishi and Hiraga 1980, 1982). In male Wistar rats receiving di-noctylphthalate 
at a concentration of 2% in the diet (approximately 2,000 mg/kg/day), food intake was 
significantly (p < 0.01) increased after 3 days when compared with controls (13.7 versus 
19.5 g/kg/rat), and body weight was significantly (p < 0.05) increased after 10 days relative to controls 
(204 versus 220 g/rat). By days 11-21, however, the values for both parameters returned to control 
levels (Mann et al. 1985). Male rats subjected to a single intraperitoneal dose of diethylnitrosamine, 
partial hepatectomy, and 26 weeks of dietary exposure to 250 or 500 mg/kg/day of di-n-octylphthalate 
apparently experienced small reductions (3-7%) in body weight gain (Carter et al. 1992). Male Wistar 
rats fed 1,000 mg/kg/day of the monoester mono-n-octylphthalate for 1 week were reported to have 
depressed body weight gains during the first 2 days and reduced body weights at the experiment’s end, 
but quantitative data were not provided (Oishi and Hiraga 1982). 
 
Other Systemic Effects. No studies were located regarding other systemic effects in humans after oral 
exposure to di-n-octylphthalate. 
 
After a 14-day exposure of CD-l mice to 1,800, 3,600, 7,500, or 15,000 mg/kg/day, a rough hair coat 
was noted in four to six out of eight animals of both sexes at 15,000 mg/kg/day (Heindel et al. 1989; 
NTP 1985). 
 
2.2.2.3 Immunological and Lymphoreticular Effects 
 
No studies were located regarding immunological or lymphoreticular effects in humans after oral 
exposure to di-n-octylphthalate. 
 
Limited data suggest that di-n-octylphthalate can exert immunotoxic effects in rats and mice after acute 
oral exposure to relatively high doses. Male rats exposed by gavage once per day for 5 days to 0, 
2,685, 5,370, or 10,740 mg/kg/day of di-n-octylphthalate (acute LD50 was 53,700 mg/kg) did not 
display any signs of overt toxicity, but did exhibit a depletion of cells in the periarteriolar lymphoid 
sheet of the spleen that the study authors noted as dose dependent, although doses at which these 
effects were observed were not identified (Dogra et al. 1987). Dose-dependent cellularity changes in 
the thymus resulted in a loss of distinction between the cortex and the medulla, and germinal center 
activity was diminished in regional and peripheral lymph nodes. In response to the intraperitoneal 
injection of sheep red blood cells (SRBC), the number of IgM-producing spleen cells was significantly 
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(p < 0.001) reduced to approximately 10% or 5% of the control value in rats exposed to the mid- and
high-doses, respectively. There was a concomitant, dose-dependent, 1,000-fold reduction in serum
anti-SRBC antibodies. Phagocytic and metabolic activities of peritoneal exudate cells were also
reduced by up to 30-40%. When challenged by subcutaneous inoculation of 1,000 larvae from the
parasite Nippostrangylus brasiliensis, 10-day worm counts were indicated to be significantly elevated
by mid- and high-dose treatments (19% and 30%, respectively) when compared with controls. Finally,
mortality was increased from 2- to 2.5-fold in rats treated with 10,740 mg/kg/day di-n-octylphthalate
(versus controls) when they were subsequently challenged with intravascular injections of 125 or
250 pg of lipopolysaccharide endotoxin from Escherichia coli.
The immune system of the mouse may also be susceptible to the effects of acute oral exposures to
di-n-octylphthalate (Dogra et al. 1989). Three-month-old Swiss albino mice were exposed to di-n-
octylphthalate by gavage for 5 days at 0, 650, or 2,600 mg/kg/day (acute LD50 was 13,000 mg/kg).
Mice were subsequently exposed by intraperitoneal injection to either encephalomyocarditis virus or
the malarial protozoan, Plasmodium berghei. Maximum mortality levels were reached 8-10 days after
viral infection and were 20% (0 mg/kg/day), 40% (650 mg/kg/day), and 70% (2,600 mg/kg/day).
Malarial lethality reached plateau levels 4-l 1 days postinfection of approximately 20% (0 mg/kg/day),
25% (650 mg/kg/day), and 70% (2,600 mg/kg/day), then increased to 55%, 70%, and 85%,
respectively, by postinfection day 19. Respective mean survival times were calculated to be 13.50,
12.15, and 6.25 days. During the first 14 days after protozoa1 infection, the percentage of mouse
erythrocytes infected with the parasite in the high-dose group was consistently and significantly
(p < 0.01 or 0.05) higher than in the control group. Significant increases were generally not observed
in the low-dose group.
Both of these studies did not contain positive controls, and both omitted experimental details and much
quantitative data. In addition, no proof of compound identity was provided and the dose levels might
be considered high enough to risk inducing overt or generalized systemic toxicity. However, the
authors indicated that no signs of gross or other organ toxicity were observed, and previously
discussed studies appear, in general, to indicate only adverse hepatic effects following acute oral
exposure to di-n-octylphthalate. In combination, these studies suggest that acute oral exposure to high
doses of di-n-octylphthalate, at least in the rat and the mouse, may result in compromised immune
responses to bacterial, viral, protozoan, or other parasitic infection.
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The highest NOAEL values and all LOAEL values from each reliable study for immunological effects 
in each species and duration category are recorded in Table 2-l and plotted in Figure 2-l. 
 
2.2.2.4 Neurological Effects 
 
No studies were located regarding neurological effects in humans after oral exposure to 
di-n-octylphthalate. 
 
Limited data from one study on CD-l mice indicate that acute and intermediate dietary exposures to 
di-n-octylphthalate at doses of up to 15,000 mg/kg/day produced virtually no effect on clinical signs of 
toxicity (Heindel et al. 1989; Morrissey et al. 1989; NTP 1985). No clinical signs of neurotoxicity 
were noted after a 14-day exposure to 1,800, 3,600, 7,500, or 15,000 mg/kg/day; rough hair coats were 
noted at the highest dose. No clinical signs of neurotoxicity were observed in the mice following 
exposure to 1,820, 3,520, or 7,460 mg/kg/day for 105 days, nor in the offspring of the high-dose 
group that were exposed via lactation followed by feed for 85-105 days to an average di-n-octylphthalate 
dose of 8,640 mg/kg/day. 
 
2.2.2.5 Reproductive Effects 
 
No studies were located regarding reproductive effects in humans after oral exposure to 
di-n-octylphthalate. 
 
The results of several acute- or intermediate-duration rodent studies indicate that the potential of 
di-n-octylphthalate exposure to cause adverse reproductive effects is very low. When male rats were 
exposed by gavage to 2,800 mg/kg/day of di-n-octylphthalate for either 4 or 10 days, no testicular 
atrophy (weight loss or histological lesions), testicular zinc loss, or weight loss of the prostate or 
seminal vesicles were observed (Foster et al. 1980; Gray and Butterworth 1980). Such effects were 
induced by di-n-butylphthalate, di-n-pentylphthalate, di-n-hexylphthalate, and di(2-ethylhexyl)phthalate, 
but not by the methyl, ethyl, n-propyl, or n-heptylphthalate diesters. No adverse effects on testis 
weight or histopathology were found in male rats exposed to up to 5,000 ppm (402.9 mg/kg/day) of 
di-n-octylphthalate in the diet for 13 weeks (Poon et al. 1995). Similarly, no effect on testis weight, 
gross morphology, or histopathology was found in male rats receiving dietary exposure to 
approximately 2,000 mg/kg/day for 10 or 21 days (Mann et al. 1985). In another study in which male 
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rats were fed a diet containing 1,000 mg/kg/day of di-n-octylphthalate for 1 week, the absence of 
effect on absolute and relative testis weight was confirmed, and no effect was found on testicular 
concentrations of testosterone or dihydrotestosterone; however, a significant (15%, p < 0.05) reduction 
in testicular zinc concentration was observed (Oishi and Hiraga 1980). One or more of these 
parameters was also altered by di-o-butylphthalate, diisobutylphthalate (DiBP), dimethyl phthalate 
(DMP), diethyl phthalate (DEP), di(2-ethylhexyl)phthalate, and phthalic acid (PA). These data are 
insufficient to clarify the precise relationship among testicular atrophy, high testosterone, and low zinc, 
but the study authors speculated that testicular atrophy may depend on phthalate induction of elevated 
levels of testosterone in the testis, accompanied by reduced zinc levels in both the testis and the liver. 
 
Some small, but statistically significant (p < 0.05), changes in testicular mitochondrial respiratory 
functions were observed in 35-day-old male rats 6 hours after they had received a single oral dose of 
2,000 mg/kg di-n-octylphthalate by gavage (Oishi 1990). Oxygen consumption of mitochondrial 
preparations from the testis during state 3 respiration (succinate respiration in the presence of 
adenosine diphosphate [ADP]; phosphorylation) was reduced by 20% when compared with untreated 
control values, and the respiratory control ratio of state 3 to state 4 respiration (“resting” succinate 
respiration in the absence of ADP), which is a measure of respiration dependency on ADP, was also 
slightly reduced by 8%. Pyruvate and lactate concentrations were not changed, nor was 
phosphorylative activity (the state 3 ratio of ADP to oxygen consumption). These effects were 
generally less extensive than those induced by di(2-ethylhexyl)phthalate treatment. Routine 
histopathological examination showed no changes in the seminiferous tubule structure in 6-8 week old 
Wistar rats after single gavage doses of 2,000 mg/kg/day on each of 2 consecutive days (Jones et al. 
1993). However, electron microscopic examination revealed vesiculation of the smooth endoplasmic 
reticulum and increased stacking into parallel cistemae in some Leydig cells, but no mitochondrial 
swelling or degeneration. This study is limited, however, because the tabular listing of effects noted 
for di-n-octylphthalate in this paper shows no vesiculation of smooth endoplasmic reticulum (Jones et 
al. 1993). 
 
Finally, one mouse reproductive-developmental toxicity study performed according to the NTP 
Continuous Breeding Protocol was reported in three papers (Heindel et al. 1989; Morrissey et al. 1989; 
NTP 1985). Dietary exposure of F0 generation male and female CD-l mice for 105 days to doses of 
0, 1,820, 3,620, or 7,460 mg/kg/day of di-n-octylphthalate failed to cause any reduction in fertility 
index (percent fertile pairs) or number of litters/pair. In contrast, at least one of these parameters was 
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significantly reduced after exposure to di-n-propylphthalate or di-n-pentylphthalate (8,600 mg/kg/day 
of di-n-propylphthalate and 2,160 mg/kg/day of di-n-pentylphthalate completely inhibited fertility). 
Similarly, F1 generation mice exposed via lactation and then feed to an average di-n-octylphthalate 
dose of 8,640 mg/kg/day for 85-105 days exhibited a statistically significant (p < 0.05) reduction in 
seminal vesicle weight, but no significant changes were noted for testis, cauda epididymis, or prostate 
weights, or for sperm concentration, percent mobile sperm, or percent abnormal sperm. In female 
mice, estrous cycle length was not altered, and no reproductive tract organ weight or histopathological 
changes were observed. These findings confirm that di-n-octylphthalate has a low potential for 
inducing reproductive toxicity following oral exposure. 
 
The highest NOAEL values and all LOAEL values from each reliable study for reproductive effects in 
each species and duration category are recorded in Table 2- 1 and plotted in Figure 2-l. 
 
2.2.2.6 Developmental Effects 
 
No studies were located regarding developmental effects in humans after oral exposure to 
di-n-octylphthalate. 
 
In a preliminary developmental toxicity screening study, female CD-l mice received 9,780 mg/kg/day 
of di-n-octylphthalate by gavage once per day during gestation days 6-13 (Hardin et al. 1987; NIOSH 
1983). The following data were recorded: the number of pups born alive; total litter weight, pup 
survival, and litter weight gain immediately after birth and on postpartum day 3; maternal survival and 
weight gain from gestation day 6 to postpartum day 3; and the number of viable litters. The test 
material given was undiluted di-n-octylphthalate; the maximum feasible dose was considered to have 
been administered because an oral LD10 (the preferred dose) could not be established due to a lack of 
toxicity. The di-n-octylphthalate group varied significantly (p < 0.05) from its concurrent corn oil 
control group only in reduced number of livebom pups per litter (10.2+2.8 versus 11.5+1.7; 11% less 
than control) and reduced pup weight gain (0.6+0.l g versus 0.7+0.2 g; 14% change from control). 
However, the concurrent control values for these two parameters (especially for the number of liveborn 
pups per litter) were unusually high, and the authors reported that these two parameters were generally 
higher than those of other control groups from the same study, thus casting additional uncertainty on 
the biological relevance of these statistically significant changes. 
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The only other oral study located that examined developmental effects was the NTP Continuous 
Breeding Protocol study previously discussed in Section 2.2.2.5 (Heindel et al. 1989; Morrissey et al. 
1989; NTP 1985). F0 generation CD-l mice were exposed to di-n-octylphthalate doses of 0, 1,820, 
3,620, or 7,460 mg/kg/day for 105 days. F1 generation mice (from the F0 high-dose group) were 
subsequently exposed via lactation and then via feed to an average di-n-octylphthalate dose of 
8,640 mg/kg/day for 85-105 days. In neither case were any significant effects noted for the number 
of live pups per litter, the proportion of pups born alive, pup sex ratio, or the live pup mean weight. 
 
The combined results of these two studies indicate that di-n-octylphthalate probably has a very low 
potential to induce developmental toxicity, especially in view of the very high doses that were 
evaluated. The highest NOAEL values and all LOAEL values from each reliable study for 
developmental effects in each species and duration category are recorded in Table 2-l and plotted in 
Figure 2- 1. 
 
2.2.2.7 Genotoxic Effects 
 
No studies were located regarding genotoxic effects in humans or animals after oral exposure to 
di-n-octylphthalate. 
 




No studies were located regarding cancer in humans after oral exposure to di-n-octylphthalate. 
 
Two studies were located in which rats received di-n-octylphthalate dietary exposures of 250 or 
500 mg/kg/day for either 10 or 26 weeks (Carter et al. 1992; DeAngelo et al. 1986). Five male rats 
were first initiated with a single subcarcinogenic intraperitoneal dose of diethylnitrosarnine (30 mg/kg), 
followed by partial hepatectomy. Di-n-octylphthalate caused substantial increases in gamma-
glutamyltranspeptidase (GGT) positive liver foci when compared with the controls (e.g., from 3.5 to 
20.8 foci/cm2) or in hepatic levels of marker enzymes for altered cellular foci (GGT and glutathione 
S-transferase [GST]). Only a slight increase (threefold) was observed for carnitine acetyltransferase 
(CAT) activity, a marker for peroxisome proliferation. In contrast, while inducing CAT activity 
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37-40-fold, di(2-ethylhexyl)phthalate and mono(ethylhexyl)phthalate actually inhibited the foci-associated
parameters. These results, although not definitive, suggest that di-n-octylphthalate may




No studies were located regarding death in humans or animals following dermal exposure to di-n-
octylphthalate.
2.2.3.2 Systemic Effects
No studies were located regarding respiratory, cardiovascular, gastrointestinal, hematological,
musculoskeletal, hepatic, or renal effects in humans or animals after dermal exposure to di-n-
octylphthalate.
Dermal and ocular effects observed after dermal exposure are discussed below.
Dermal Effects. No studies were located regarding dermal effects in humans following dermal
exposure to di-n-octylphthalate.
In a toxicity summary submitted by Eastman Kodak Company (1978), di-n-octylphthalate was reported
to be a slight skin irritant when applied to the depilatated skin of guinea pigs. However, di-n-
octylphthalate was not a skin sensitizer in guinea pigs.
Ocular Effects. No studies were located regarding ocular effects in humans following dermal
exposure to di-n-octylphthalate.
In a toxicity summary submitted by Eastman Kodak Company (1978), ocular administration of di-n-
octylphthalate resulted in slight conjunctival irritation and no cornea1 damage. No further details were
provided.
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2.2.3.3 Immunological and Lymphoreticular Effects 
 
No studies were located regarding immunological and lymphoreticular effects in humans following 
dermal exposure to di-n-octylphthalate. 
 
Di-n-octylphthalate was negative in a skin sensitization test in guinea pigs (Eastman Kodak Company 
1978). No further details were provided in this summary report. 
 
No studies were located regarding the following health effects in humans or animals after dermal 
exposure to di-n-octylphthalate: 
 
2.2.3.4 Neurological Effects 
2.2.3.5 Reproductive Effects 
2.2.3.6 Developmental Effects 
2.2.3.7 Genotoxic Effects 
 









No studies were located regarding the toxicokinetics of di-n-octylphthalate in humans or animals 
following inhalation or dermal exposure. Information on the toxicokinetics of di-n-octylphthalate in 
humans following oral exposure is not available. There are studies that provide indirect evidence for 
the oral absorption of di-n-octylphthalate in animals (Albro and Moore 1974; Oishi 1990; Poon et al. 
1995); however, quantitative information is lacking on the rate and extent of absorption following oral 
exposure to di-n-octylphthalate. Information on the distribution of di-n-octylphthalate is limited to oral 
studies in rats by Oishi (1990), which reported the identification of mono-n-octylphthalate in blood and 
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testes within 1-24 hours (plasma peak at 3 hours, testes peak at 6 hours) after dosing, and by Poon et
al. (1995), which reported di-n-octylphthalate residues in liver and adipose tissue. The metabolism of
di-n-octylphthalate following acute exposure has been studied in animals in vivo and in vitro
(Albro and Moore 1974; Brodsky et al. 1986; Lake et al. 1977), and the data indicate that, like most
phthalate esters, di-n-octylphthalate can be hydrolyzed at one or both ester linkages to produce the
monoester as well as phthalic acid (minor metabolite). As with other phthalates, subsequent oxidation of
the remaining arylester to short-chained carboxyls, alcohols, and ketones has been demonstrated.
Although one study seems to indicate that urine is the major elimination route of di-n-octylphthalate
metabolites following oral exposure (Albro and Moore 1974), no quantitative information on the rate
and extent of excretion is available. No information is available on the mechanism of action of di-n-
octylphthalate with respect to its absorption, distribution, metabolism, or excretion.
2.3.1 Absorption
2.3.1.1 Inhalation Exposure
No studies were located regarding the absorption of di-n-octylphthalate in humans or animals
following inhalation exposure.
2.3.1.2 Oral Exposure
No studies were located regarding the absorption of di-n-octylphthalate in humans following oral
exposure.
Evidence of oral absorption in rats is demonstrated in the studies by Albro and Moore (1974), Oishi
(1990), and Poon et al. (1995). Forty-eight hours after a gavage dose of di-n-octylphthalate,
metabolites were detected in the urine. The major metabolite (60% of the metabolites in urine) was
derived from the monoester (Albro and Moore 1974). The mono-n-octylphthalate metabolite was
found in the blood and testes of rats from l-24 hours after oral dosing with peak levels reported at
3 hours (for blood) and 6 hours (for testes) (Oishi 1990). Di-n-octylphthalate was found in the liver
and adipose tissue of rats after they were fed this compound for 13 weeks in dietary concentrations up
to 5,000 ppm, indicating its absorption (Poon et al. 1995). Although there are insufficient quantitative
data for estimating the oral absorption rate, di-n-octylphthalate appears to be absorbed readily;
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however, it may have to be converted to mono-n-octylphthalate for intestinal absorption to occur (Lake 
et al. 1977). 
 
2.3.1.3 Dermal Exposure 
 
No studies were located regarding the absorption of di-n-octylphthalate in humans or animals 




2.3.2.1 Inhalation Exposure 
 
No studies were located regarding the distribution of di-n-octylphthalate in humans or animals 
following inhalation exposure. 
 
2.3.2.2 Oral Exposure 
 
No studies were located regarding the distribution of di-n-octylphthalate in humans following oral 
exposure. 
 
Following a single oral dose of 2,000 mg/kg of di-n-octylphthalate in rats, mono-n-octylphthalate was 
detected in blood with peak levels observed at 3 hours and in the testes with peak levels observed at 
6 hours (Oishi 1990). The biological half-life and mean residence time of mono-n-octylphthalate in 
blood were 3.3 and 5.4 hours, respectively. After 13 weeks of oral exposure of rats to di-n-octylphthalate 
in the diet at concentrations up to 5,000 ppm (350 and 403 mg/kg/day in males and 
females, respectively), the livers contained di-n-octylphthalate residues that were either below or just 
slightly above the detection limit (<3 ppm) (Poon et al. 1995). The adipose tissue of rats fed 
5,000 ppm showed di-n-octylphthalate residue levels of 15 ppm (males) and 25 ppm (females). This 
study is limited in that it did not analyze tissues for the presence of metabolites. 
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2.3.2.3 Dermal Exposure 
 
No studies were located regarding the distribution of di-n-octylphthalate in humans or animals 




Di-n-octylphthalate is readily converted to mono-n-octylphthalate, its major metabolite, by hydrolysis 
of a single ester group. Mono-n-octylphthalate is detected in the blood of rats within an hour after 
oral administration of 2,000 mg/kg di-n-octylphthalate (Oishi 1990). Hydrolysis of di-n-octylphthalate 
at both ester linkages to produce phthalic acid (minor metabolite) may also occur, but this conversion 
does not occur readily. 
 
As shown in Figure 2-2, mono-n-octylphthalate can undergo ω-, ω-l, α- and β-oxidation to form 
phthalate monoesters (carboxy, keto, or hydroxy esters), which are the major metabolites detected in 
the urine (Albro and Moore 1974). Forty-eight hours after the administration of a gavage dose of 
559 mg/kg/day of di-n-octylphthalate in male CD rats for 2 days, 31% of the administered dose was 
recovered in the urine as derivatives of the monoester varying in the length of the alkyl side chains 
(with terminal or subterminal carboxyl, keto, or hydroxyl moieties). The principal urinary metabolite 
[-(CH2)3COOH side chain] resulted from an initial ω-oxidation and two β-oxidations of the n-octyl 
side chain (Albro and Moore 1974). The remaining amount detected in the urine was represented by 
free phthalic acid and mono-n-octylphthalate. The unmetabolized parent compound was not detected. 
 
Evidence of the formation of mono-n-octylphthalate and phthalate ester metabolites has been shown in 
in vitro studies. The appearance of mono-n-octylphthalate was observed with preparations of human 
small intestine, rat liver and intestine, ferret liver and intestine, and baboon liver and intestine (Lake et 
al. 1977). However, the amount of phthalic acid and other metabolites in these preparations was either 
minimal or not detected. The study authors concluded that di-n-octylphthalate is probably absorbed 
primarily as mono-n-octylphthalate (Lake et al. 1977). An in vitro study reported the formation of 
five keto acids and two diols when metabolic oxidation of the alkyl groups of di-n-octylphthalate was 
simulated abiotically (Brodsky et al. 1986). Therefore, the in vivo and in vitro data indicate that major 
oxidation may occur in the remaining alkyl chain after di-n-octylphthalate has been hydrolyzed to the 
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monoester. It is not known for certain whether di-n-octylphthalate is absorbed by the intestine or 




2.3.4.1 Inhalation Exposure 
 
No studies were located regarding the excretion of di-n-octylphthalate in humans or animals following 
inhalation exposure. 
 
2.3.4.2 Oral Exposure 
 
No studies were located regarding the excretion of di-n-octylphthalate in humans following oral 
exposure. 
 
Following gavage administration of 559 mg/kg/day of di-n-octylphthalate to rats, metabolites 
accounting for 31% of the administered dose were detected in the urine at 48 hours postexposure 
(Albro and Moore 1974). 
 
2.3.4.3 Dermal Exposure 
 
No studies were located regarding the excretion of di-n-octylphthalate in humans or animals following 
dermal exposure. 
 
2.4 MECHANISMS OF ACTION 
 
No studies were located regarding mechanisms of action for absorption or distribution of di-n-
octylphthalate in humans or animals following inhalation, oral, or dermal exposure.  
 
Di-n-octylphthalate has been shown to be a mild liver toxin at high doses in acute- and intermediate-
duration studies in rodents. While the mechanism of action for these hepatic effects is not known, din- 
octylphthalate does not appear to behave like other phthalate esters such as di(2-ethylhexyl)phthalate, 
which have been shown to be hypolipidemic peroxisome proliferators. Instead, the liver changes 
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associated with exposure to di-n-octylphthalate are characterized by marked centrilobular accumulation 
of fat and loss of glycogen, accompanied by reduced glucose-6-phosphatase activity and some 
centrilobular necrosis. However, these effects have been noted in only one study (Mann et al. 1983, 
and were not seen in the multigeneration study in mice by NTP (Heindel et al. 1989; Morrissey et al. 
1989; NTP 1985) or other studies in rats (Lake et al. 1984, 1986; Oishi and Hiraga 1980). 
 
2.5 RELEVANCE TO PUBLIC HEALTH 
 
Populations living in areas surrounding hazardous waste sites may be exposed to di-n-octylphthalate 
primarily via ingestion of drinking water. Other possible routes of exposure are inhalation of 
contaminated air or dermal contact with contaminated water. For the general population (i.e., 
including individuals not living in the vicinity of hazardous waste sites), most exposure to di-n-
octylphthalate occurs through the use of consumer products containing it. For example, exposure to 
di-n-octylphthalate can occur in people receiving medical treatments that involve the use of polyvinyl 
chloride tubing from which di-n-octylphthalate can leach. Exposure of the general population can also 
occur by ingestion of contaminated foods into which di-n-octylphthalate has leached from packaging 
materials, by ingestion of contaminated seafood, by drinking contaminated water, or by inhalation of 
contaminated air. Occupational exposure to di-n-octylphthalate can occur in industrial facilities where 
it is used in the manufacture of plastics or consumer products. 
 
No information is available on the possible health effects of di-n-octylphthalate in humans. The liver 
is the only target organ that has been identified for di-n-octylphthalate in animals following acute- and 
intermediate-duration oral and parenteral exposure. Acute parenteral studies in animals provided data 
that suggest that di-n-octylphthalate may have adverse effects on the immune system, but the relevance 
of this route of exposure to humans exposed to di-n-octylphthalate at hazardous waste sites is not 
known. Di-n-octylphthalate does not appear to induce reproductive toxicity as do other phthalate 
esters [e.g., di(2-ethylhexyl)phthalate], and oral developmental toxicity studies with di-n-octylphthalate 
have yielded negative results. A decrease in fetal weight and an increase in the incidence of visceral 
malformations were noted in the offspring of rats administered high doses of di-n-octylphthalate by 
intraperitoneal injection, but the relevance of this study to humans is not known. The only available 
data on the potential carcinogenicity of di-n-octylphthalate suggest that it may be a tumor promoter, 
but nothing is known about the ability of this compound to induce cancer by itself. In vitro 
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genotoxicity data indicate that di-n-octylphthalate is not genotoxic, but there is no information on the 
in vivo genotoxic potential of this compound. 
 




No inhalation MRLs were derived for di-n-octylphthalate. No data exist on the effects of acute-, 




Since no human studies were available, animal studies were used for the derivation of the MRL. 
 
• An MRL of 3 mg/kg/day has been derived for acute oral exposure to di-n-octylphthalate. This 
MRL is based on liver effects observed in rats administered di-n-octylphthalate via gavage at a 
dose of 1,000 mg/kg/day (Lake et al. 1986). The hepatic effects consisted of a statistically 
significant (p<0.01) 17% increase in relative liver weight and a statistically significant (p<0.05) 
reduction in enzyme (7-ethoxycoumarin O-deethylase) activities. The LOAEL was divided by an 
uncertainty factor of 300 (3 for use of a minimal LOAEL, 10 for extrapolation from animals to 
humans, and 10 for human variability). The choice of liver toxicity as the basis for the acute 
oral MRL is supported by necrosis and mild hepatic fatty changes seen in other acute- and 
intermediate-duration studies in rats (DeAngelo et al. 1986; Lake et al. 1984; Mann et al. 1985; 
Poon et al. 1995). 
 
• An MRL of 0.4 mg/kg/day has been derived for intermediate-duration oral exposure to di-n-
octylphthalate. This MRL is based on a NOAEL of 40.8 mg/kg/day for liver effects that were 
observed in rats fed di-n-octylphthalate in the diet at a dose of 350.1 mg/kg/day (males) or 
402.9 mg/kg/day (females) (Poon et al. 1995). These hepatic effects consisted of a statistically 
significant (p<0.05) increase in hepatic ethoxyresorufin-0-deethylase activity and histological 
changes in hepatic architecture, including accentuation of zonation and perivenous cytoplasmic 
vacuolation. Thyroid toxicity (decreased colloid density and reduced follicle size) was also noted 
at this concentration. The NOAEL was divided by an uncertainty factor of 100 (10 for 
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extrapolation from animals to humans and 10 for human variability). Support for the use of 
hepatic toxicity as the basis of the intermediate MRL is provided by other studies that show 
necrosis and other fatty changes after acute- and intermediate-duration exposure of rats 
(DeAngelo et al. 1986; Lake et al. 1984, 1986; Mann et al. 1985). 
 
No chronic oral MRLs were derived for di-n-octylphthalate because no reliable data exist on adverse 
effects of chronic-duration oral exposure to di-n-octylphthalate. 
 
Death. No studies were located regarding death in humans after exposure to di-n-octylphthalate. 
LD50 values in rodents have been reported for di-n-octylphthalate following both oral and parenteral 
administration. Oral LD50 values are reported to be 53,700 mg/kg for rats (Dogra et al. 1987) and 
13,000 mg/kg for mice (Dogra et al. 1989). The intraperitoneal LD50 in rats is >48,900 mg/kg (Singh 
et al. 1972). These values indicate that di-n-octylphthalate is relatively nonlethal and should not 





Gastrointestinal Effects. No studies were located regarding gastrointestinal effects in humans or 
animals following inhalation or dermal exposure to di-n-octylphthalate. No studies were located 
regarding gastrointestinal effects in humans following oral exposure to this compound. 
 
No pathological changes of the pancreas were exhibited by rats following intermediate-duration 
exposure to di-n-octylphthalate in the diet (Mann et al. 1985). The available information is 
insufficient to assess whether adverse gastrointestinal effects are likely to occur in humans exposed to 
di-n-octylphthalate in the vicinity of hazardous waste sites, but the limited information discussed above 
suggests that such effects are unlikely. 
 
Hematological Effects. No studies were located regarding hematological effects in humans or animals 
following inhalation or dermal exposure to di-n-octylphthalate. No studies were located regarding 
hematological effects in humans following oral exposure to this compound. 
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The data from one intermediate-duration oral study in rats suggests that di-n-octylphthalate does not
cause any hematological effects (Poon et al. 1995), but due to the limited data available, this cannot be
stated with certainty.
Hepatic Effects. No studies were located regarding hepatic effects in humans or animals following
inhalation or dermal exposure to di-n-octylphthalate. No studies were located regarding hepatic effects
in humans following oral exposure to this compound.
Results from acute- and intermediate-duration oral studies in small numbers of rats conducted at
relatively high doses suggest that the liver is a target for di-n-octylphthalate-induced toxicity. Hepatic
effects noted in these studies include gross changes in appearance, small but statistically significant
increases in relative organ weight, ethoxyresorufin-O-deethylase activity, alteration in the activity of
several hepatic microsomal enzymes, loss of centrilobular glycogen, cytoplasmic vacuolation,
accentuation of zonation, proliferation and dilation of the smooth endoplasmic reticulum accompanied
by some loss of rough endoplasmic reticulum, fat accumulation, and occasional necrosis (Lake et al.
1984, 1986; Mann et al. 1985; Oishi and Hiraga 1980, 1982; Poon et al. 1995). In addition, rats
exposed to dietary concentrations of mono-n-octylphthalate equivalent to 1,000 mg/kg/day exhibited a
variety of significant alterations in serum lipid composition, reflecting a possible effect on hepatic
metabolism of lipids (Oishi and Hiraga 1982). However, di-n-octylphthalate does not appear to
behave like other phthalate esters such as di(2-ethylhexyl)phthalate, which has been shown to be a
hypolipidemic peroxisome proliferator. Based on these results, adverse hepatic effects may occur in
individuals living in the vicinity of hazardous waste sites if di-n-octylphthalate is present at sufficiently
high levels in the substances consumed (e.g., water).
Renal Effects. No studies were located regarding renal effects in humans or animals following
inhalation or dermal exposure to di-n-octylphthalate. No studies were located in humans following
oral exposure to this compound.
Limited information obtained from oral studies in rats and mice suggests that exposure to di-n-
octylphthalate, even at relatively high doses, does not affect the kidney, as evidenced by a lack of
change in kidney weight or kidney gross and microscopic pathology (Foster et al. 1980; Heindel et al.
1989; Mann et al. 1985; Morrissey et al. 1989; NTP 1985; Oishi and Hiraga 1980; Poon et al. 1995),
although one study noted increased absolute kidney weight in rats with no gross or microscopic
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change in the kidney (Heindel et al. 1989; Morrissey et al. 1989; NTP 1985). Therefore, based on this 
limited information, it does not appear that exposure to di-n-octylphthalate at the levels expected to be 
present in the vicinity of hazardous waste sites is likely to induce adverse renal effects in humans. 
 
Endocrine Effects. No studies were located regarding endocrine effects in humans or animals 
following inhalation or dermal exposure to di-n-octylphthalate. No studies were located in humans 
following oral exposure to this compound. 
 
Data from acute- and intermediate-duration studies in rats suggests that di-n-octylphthalate may cause 
adverse effects on the thyroid gland. The effects observed include decreased thryoxine levels, 
histopathological changes (reduced follicle size and colloid density), and ultrastructural changes 
(enlargement of lysosomes and Golgi apparatus, mitochondrial damage) (Hinton et al. 1986; Poon et 
al. 1995). Further data are necessary to determine whether thyroid effects might occur in persons 
living in the vicinity of hazardous waste sites as a result of exposure to di-n-octylphthalate. 
 
Dermal Effects.  No studies were located regarding dermal effects in humans or animals following 
inhalation or dermal exposure to di-n-octylphthalate. No studies were located in humans following 
oral exposure to this compound. 
 
In a toxicity summary submitted by Eastman Kodak Company (1978), di-n-octylphthalate was reported 
to be a slight skin irritant when applied to the depilatated skin of guinea pigs, but not a skin sensitizer 
in guinea pigs. No further details were provided; however, it does not appear that di-n-octylphthalate 
is likely to cause dermal irritation. 
 
Ocular Effects. No studies were located regarding ocular effects in humans or animals following 
inhalation or dermal exposure to di-n-octylphthalate. No studies were located in humans following 
oral exposure to this compound. 
 
In a toxicity summary submitted by Eastman Kodak Company (1978), ocular administration of di-n-
octylphthalate in guinea pigs resulted in slight conjunctival irritation and no cornea1 damage. No 
further details were provided; however, it does not appear that di-n-octylphthalate is likely to cause 
ocular irritation. 
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Body Weight Effects. No studies were located regarding body weight effects in humans or animals 
following inhalation or dermal exposure to di-n-octylphthalate. No studies were located in humans 
following oral exposure to this compound. 
 
Data from various acute- and intermediate-duration oral studies in rats and mice conducted at relatively 
high doses indicate that exposure to di-n-octylphthalate does not adversely affect body weight gain or 
food consumption (Carter et al. 1992; Heindel et al. 1989; Mann et al 1985; Morrissey et al. 1989; 
NTP 1985; Oishi and Hiraga 1980, 1982; Poon et al. 1995). 
 
Other Systemic Effects. No studies were located regarding other systemic effects in humans or 
animals following inhalation or dermal exposure to di-n-octylphthalate. No studies were located in 
humans following oral exposure to this compound. 
 
Although a rough hair coat was observed in mice fed 15,000 mg/kg/day for 14 days (Heindel et al. 
1989; NTP 1985), it is not expected that other systemic signs of toxicity would be observed in 
individuals exposed to di-n-octylphthalate in the area surrounding hazardous waste sites. 
 
Immunological and Lymphoreticular Effects. No studies were located regarding immunological 
or lymphoreticular effects in humans or animals following inhalation exposure to di-n-octylphthalate, 
or in humans following oral or dermal exposure to this compound. 
 
Limited data in rats and mice suggest that di-n-octylphthalate can exert immunotoxic effects following 
acute oral or parenteral exposure to relatively high doses. These effects are reflected in changes in the 
weight and morphology of various lymphoreticular organs (thymus, spleen, and lymph nodes), altered 
activity of humoral antibody-forming cells and cellular mediators of immunity, and reduced resistance 
to bacterial, viral, protozoan, and other parasitic infection (Dogra et al. 1985, 1987, 1989). 
 
The available information suggests that exposure to di-n-octylphthalate may adversely affect immune 
function in individuals living in the vicinity of hazardous waste sites if the individuals ingest 
sufficiently high levels. Because of its low vapor pressure, exposure to high levels of di-n-octylphthalate 
by inhalation is not likely. 
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Neurological Effects. No studies were located regarding neurological effects in humans or animals 
following inhalation or dermal exposure to di-n-octylphthalate. No studies were located regarding 
neurological effects in humans following oral exposure to di-n-octylphthalate. 
 
No clinical signs of neurotoxicity were noted in acute- and intermediate-duration dietary exposure 
studies using mice (Heindel et al. 1989; NTP 1985). Although these data are limited, it is not believed 
that the low-level exposure to di-n-octylphthalate that occurs at hazardous waste sites will result in 
neurotoxicity. 
 
Reproductive Effects. No studies were located regarding reproductive effects in humans or animals 
following inhalation or dermal exposure to di-n-octylphthalate. No studies were located in humans 
following oral exposure to this compound. However, di-n-octylphthalate has been shown to cause 
significant decreases in human sperm motility in vitro (Fredricsson et al. 1993). 
 
The results of several acute- and intermediate-duration oral studies in rodents indicate that the potential 
of di-n-octylphthalate to cause adverse reproductive effects is low. Unlike other phthalate esters such 
as di(2-ethylhexyl)phthalate, di-n-octylphthalate does not appear to adversely affect testicular function 
or morphology (Foster et al. 1980; Gray and Butterworth 1980; Heindel et al. 1989; Morrissey et al. 
1989; NTP 1985; Oishi 1990; Oishi and Hiraga 1980; Poon et al. 1995). However, some 
ultrastructural alterations in Leydig cells, including vesiculation of the smooth endoplasmic reticulum, 
were noted in rats administered di-n-octylphthalate by gavage on 2 consecutive days (Jones et al. 
1993). Leydig cells obtained from rats that were cultured and stimulated by LH to measure cellular 
integrity by examining testosterone output showed decreased testosterone production when incubated 
with mono-n-octylphthalate, the major metabolite of di-n-octylphthalate (Jones et al. 1993). 
Examination of these cells exposed in vitro showed that mono-n-octylphthalate caused an increase in 
filopodial proliferation from the cell stroma and basal lamellar processes, dilatation of the smooth 
endoplasmic reticulum, and mitochondrial swelling and degeneration. No adverse effects on the 
female estrous cycle or on any index of reproductive function were seen in a multigeneration study in 
mice (Heindel et al. 1989; Morrissey et al. 1989; NTP 1985). Thus, it is unlikely that individuals 
exposed to di-n-octylphthalate in the vicinity of hazardous waste sites are at risk for adverse 
reproductive effects resulting from exposure to this compound. 
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Developmental Effects. No studies were located regarding developmental effects in humans or
animals following inhalation or dermal exposure to di-n-octylphthalate. No studies were located in
humans following oral exposure to this compound.
The results of two oral studies in mice (one being a multigeneration reproductive toxicity study)
indicate that di-n-octylphthalate has a very low potential to induce adverse developmental effects,
especially in view of the very high doses that were evaluated in these studies (Hardin et al. 1987;
Heindel et al. 1989; Morrissey et al. 1989; NIOSH 1983; NTP 1985). No statistically significant
and/or biologically significant effects were observed with respect to the incidence of skeletal or
visceral malformations in offspring exposed in utero. A significant decrease in fetal survival was
reported in one study (Hardin et al. 1987) of mice given 9,780 mg/kg/day di-n-octylphthalate by
gavage during gestation days 6-13. A small but significant decrease in average fetal weight and a
significantly increased incidence of gross fetal malformations were observed in the offspring of rats
administered 4,890 mg/kg/day of di-n-octylphthalate by intraperitoneal injection (Singh et al. 1972).
Given that the effects seen following parenteral administration may not be relevant to human exposure
(e.g., different metabolism), the available information suggests that adverse developmental effects are
not likely to occur in humans exposed to di-n-octylphthalate in the vicinity of hazardous waste sites.
Genotoxic Effects. No studies were located that assessed the potential, if any, of
di-n-octylphthalate to induce genotoxic effects in either humans or animals exposed via the inhalation,
oral, or dermal routes. No mammalian cell assays on di-n-octylphthalate were found.
There is, however, a relatively sizable database of well-conducted microbial assays. As part of the
NTP, a series of 34 phthalates or related compounds, including di-n-octylphthalate (98%), were
evaluated for their potential to induce reverse gene mutations in the Salmonella
typhimurium/mammalian microsome preincubation assay (Zeiger et al. 1982, 1985). Concentrations of
di-n-octylphthalate ranging from 100 to 10,000 ug/plate in either the presence or absence of exogenous
metabolic activation derived from Aroclor 1254-induced rat or hamster liver fractions were not
mutagenic in S. typhimurium TA1535, TA1537, TA98, or TAL00. Similar evidence that
di-n-octylphthalate is not a mutagen for S. typhimurium strains has been reported in other
preincubation suspension assays (Seed 1982; Shibamoto and Wei 1986) and in plate incorporation
assays (Florin et al. 1980; Goodyear 1981a; Sato et al. 1994; Shibamoto and Wei 1986).
Di-n-octylphthalate levels ranging from 100 to 2,000 µg/mL (without S9), and 2,000 µg/mL (with
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S9, Aroclor 1254-induced rat liver) did not induce deoxyribonucleic acid (DNA) damage in
DNA-repair deficient E. coli p3478 (Goodyear 1981b). Di-n-octylphthalate also showed a negative
response in a prokaryotic SOS chromotest assay (Sato et al. 1994). However, the mutagenicity was
increased two-fold in the presence of di-n-octylphthalate (Sato et al. 1994).
Extracts of waste water, drinking water, soil, or sediment samples collected from various municipal
and industrial solid and/or waste water sites were found to be mutagenic in S. typhimurium TA98 and
TAL00 (Wang et al. 1990). Although di-n-octylphthalate (8.9 µg/L) was identified as one the
18 contaminants in the National Bureau of Standards reference sludge sample, several well-characterized
mutagens were among the contaminants. It is, therefore, unlikely that the mutagenic
activity uncovered in these samples was associated with di-n-octylphthalate but rather with the known
mutagens that were listed among the 18 contaminants.
Overall, the results of microbial testing indicate that di-n-octylphthalate is not a mutagen. Although
the database for in vitro genetic toxicology testing is limited, the majority of reported studies were
well conducted and showed a high degree of concordance. Based on the available information, there
is sufficient valid in vitro data to conclude that di-n-octylphthalate is devoid of genotoxic activity in
bacterial test systems. No conclusions can be reached regarding potential effects on other systems in
vitro or in vivo.
Summarized findings from the in vitro genotoxicity studies are presented in Table 2-2.
Cancer. No studies were located regarding cancer in humans or animals following inhalation or
dermal exposure to di-n-octylphthalate, and no studies were located in humans following oral exposure
to this compound.
Rats exposed to di-n-octylphthalate in the diet for either 10 or 26 weeks following a single
subcarcinogenic intraperitoneal injection of diethylnitrosamine and partial hepatectomy exhibited
increases in GGT-positive liver foci that were not associated with peroxisome proliferation (Carter et
al. 1992; DeAngelo et al. 1986). These results suggest that di-n-octylphthalate may be effective in





The carcinogenic potential of di-n-octylphthalate has not been categorized by either IARC, NTP, or
EPA.
2.6 BIOMARKERS OF EXPOSURE AND EFFECT
Biomarkers are broadly defined as indicators signaling events in biologic systems or samples. They
have been classified as markers of exposure, markers of effect, and markers of susceptibility
(NAS/NRC 1989).
Due to a nascent understanding of the use and interpretation of biomarkers, implementation of
biomarkers as tools of exposure in the general population is very limited. A biomarker of exposure is
a xenobiotic substance or its metabolite(s), or the product of an interaction between a xenobiotic agent
and some target molecule(s) or cell(s) that is measured within a compartment of an organism
(NAS/NRC 1989). The preferred biomarkers of exposure are generally the substance itself or
substance-specific metabolites in readily obtainable body fluid(s) or excreta. However, several factors
can confound the use and interpretation of biomarkers of exposure. The body burden of a substance
may be the result of exposures from more than one source. The substance being measured may be a
metabolite of another xenobiotic substance (e.g., high urinary levels of phenol can result from
exposure to several different aromatic compounds). Depending on the properties of the substance
(e.g., biologic half-life) and environmental conditions (e.g., duration and route of exposure), the
substance and all of its metabolites may have left the body by the time samples can be taken. It may
be difficult to identify individuals exposed to hazardous substances that are commonly found in body
tissues and fluids (e.g., essential mineral nutrients such as copper, zinc, and selenium). Biomarkers of
exposure to di-n-octylphthalate are discussed in Section 2.6.1.
Biomarkers of effect are defined as any measurable biochemical, physiologic, or other alteration within
an organism that, depending on magnitude, can be recognized as an established or potential health
impairment or disease (NAS/NRC 1989). This definition encompasses biochemical or cellular signals
of tissue dysfunction (e.g., increased liver enzyme activity or pathologic changes in female genital
epithelial cells), as well as physiologic signs of dysfunction such as increased blood pressure or
decreased lung capacity. Note that these markers are not often substance specific. They also may not
be directly adverse, but can indicate potential health impairment (e.g., DNA adducts). Biomarkers of
effects caused by di-n-octylphthalate are discussed in Section 2.6.2.
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A biomarker of susceptibility is an indicator of an inherent or acquired limitation of an organism’s
ability to respond to the challenge of exposure to a specific xenobiotic substance. It can be an
intrinsic genetic or other characteristic or a preexisting disease that results in an increase in absorbed
dose, a decrease in the biologically effective dose, or a target tissue response. If biomarkers of
susceptibility exist, they are discussed in Section 2.8, Populations That Are Unusually Susceptible.
2.6.1 Biomarkers Used to Identify or Quantify Exposure to Di-n-octylphthalate
Animal studies have shown that di-n-octylphthalate metabolites (primarily the corresponding phthalate
monoesters) can be measured in the urine of rats orally exposed to di-n-octylphthalate. Therefore,
these phthalate monoesters could be useful biomarkers of exposure. There are no other known
biomarkers of exposure to di-n-octylphthalate.
2.6.2 Biomarkers Used to Characterize Effects Caused by Di-n-octylphthalate
No biomarkers of effects caused by di-n-octylphthalate have been identified in humans or animals.
2.7 INTERACTIONS WITH OTHER SUBSTANCES
No studies have been identified that investigated the effects of exposure to di-n-octylphthalate together
with other chemicals. An in vivo assay using S. typhimurium TA98 showed that di-n-octylphthalate
enhanced the mutagenicity of two tryptophan pyrolysis products, which is suggestive of increased
mutagenic activity in high-temperature cooking if di-n-octylphthalate is present (Sato et al. 1994). .
2.8 POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE
A susceptible population will exhibit a different or enhanced response to di-n-octylphthalate than will
most persons exposed to the same level of di-n-octylphthalate in the environment. Reasons include
genetic make-up, developmental stage, age, health and nutritional status (including dietary habits that
may increase susceptibility, such as inconsistent diets or nutritional deficiencies), and substance
exposure history (including smoking). These parameters may result in decreased function of the
detoxification and excretory processes (mainly hepatic, renal, and respiratory) or the pre-existing
compromised function of target organs (including effects or clearance rates and any resulting
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end-product metabolites). For these reasons we expect the elderly with declining organ function and 
the youngest of the population with immature and developing organs will generally be more vulnerable 
to toxic substances than healthy adults. Populations who are at greater risk due to their unusually high 
exposure are discussed in Section 5.6, Populations With Potentially High Exposure. 
 
Studies in animals suggest that, unlike some other phthalate esters, the potential for adverse 
reproductive or developmental effects following exposure to di-n-octylphthalate by the route most 
relevant to human exposure (oral) is very low (Foster et al. 1980; Gray and Butterworth 1980; Hardin 
et al. 1987; Heindel et al. 1989; Mann et al. 1985; Morrissey et al. 1989; NIOSH 1983; NTP 1985; 
Oishi 1990; Oishi and Hiraga 1980). Therefore, it does not appear that individuals of child-bearing 
age or embryos/fetuses are likely to be unusually susceptible to the effects of di-n-octylphthalate. No 
other information is available on populations with above-average susceptibility to di-n-octylphthalate. 
 
2.9 METHODS FOR REDUCING TOXIC EFFECTS 
 
This section describes clinical practice and research concerning methods for reducing toxic effects of 
exposure to di-n-octylphthalate. However, because some of the treatments discussed may be 
experimental and unproven, this section should not be used as a guide for treatment of exposures to di-n-
octylphthalate. When specific exposures have occurred, poison control centers and medical 
toxicologists should be consulted for medical advice. 
 
2.9.1 Reducing Peak Absorption Following Exposure 
 
Following dermal exposure to di-n-octylphthalate, it has been suggested that the skin be washed 
immediately with copious amounts of soapy water (Stutz and Ulin 1992). If the eyes are exposed to 
the liquid or vapor, it has been suggested that they be thoroughly flushed with water. Following 
ingestion of di-n-octylphthalate, it has been suggested that one to two glasses of water should be 
administered (Stutz and Ulin 1992).  
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2.9.2 Reducing Body Burden
Administration of activated charcoal as an absorptive surface for di-n-octylphthalate has been
suggested (Stutz and Ulin 1992). If ingestion of large amounts of di-n-octylphthalate has occurred, the
administration of a cathartic, such as magnesium sulfate, has been shown to increase the elimination of
the substance from the gastrointestinal tract (Stutz and Ulin 1992).
2.9.3 Interfering with the Mechanism of Action for Toxic Effects
Di-n-octylphthalate has been shown to be a liver toxin at high doses in acute- and intermediate-duration
animal studies. Di-n-octylphthalate does not appear to behave like other phthalate esters, such
as di(2-ethylhexyl)phthalate, which have been shown to be hypolipidemic peroxisome proliferators.
Rather, its effects on the liver are more characteristic of other “classic hepatotoxins” (Lake et al. 1984,
1986; Mann et al. 1985). However, the specific mechanism(s) of action for inducing the hepatotoxic
effects of di-n-octylphthalate is not known. Therefore, there are currently no methods available for
interfering with the mechanism of action for the toxic effects of di-n-octylphthalate.
2.10 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with
the Administrator of EPA and agencies and programs of the Public Health Service) to assess whether
adequate information on the health effects of di-n-octylphthalate is available. Where adequate
information is not available, ATSDR, in conjunction with the National Toxicology Program (NTP), is
required to assure the initiation of a program of research designed to determine the health effects (and
techniques for developing methods to determine such health effects) of di-n-octylphthalate.
The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that if met would
reduce the uncertainties of human health assessment. This definition should not be interpreted to mean
that all data needs discussed in this section must be filled. In the future, the identified data needs will
be evaluated and prioritized, and a substance-specific research agenda will be proposed.
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2.10.1 Existing Information on Health Effects of Di-n-octylphthalate 
 
The existing data on health effects of inhalation, oral, and dermal exposure of humans and animals to 
di-n-octylphthalate are summarized in Figure 2-3. The purpose of this figure is to illustrate the 
existing information concerning the health effects of di-n-octylphthalate. Each dot in the figure 
indicates that one or more studies provide information associated with that particular effect. The dot 
does not necessarily imply anything about the quality of the study or studies, nor should missing 
information in this figure be interpreted as a “data need.” A data need, as defined in ATSDR’s 
Decision Guide for Identifying Substance-Specific Data Needs Related to Toxicological Profiles 
(ATSDR 1989a), is substance-specific information necessary to conduct comprehensive public health 
assessments. Generally, ATSDR defines a data gap more broadly as any substance-specific 
information missing from the scientific literature. 
 
As can be seen in Figure 2-3, no information is available on the health effects of di-n-octylphthalate in 
humans, and very little information is available in animals. All of the available information on the 
toxicity of di-n-octylphthalate in animals comes from studies in which this compound was 
administered by either the oral or parenteral route; no information is available from animal studies on 
the toxicity of di-n-octylphthalate following inhalation or dermal exposure. Acute oral and parenteral 
lethality studies are available in animals, and the hepatic, immunological, reproductive, and 
developmental toxicity of di-n-octylphthalate has been studied following acute- and intermediate-duration 
parenteral and/or oral exposure in rats and mice. Among reliable studies, the longest duration 
found for di-n-octylphthalate exposure by any route is in a multigeneration reproductive toxicity oral 
gavage study (85-105 days) in mice and a promotion test dietary study (182 days) in rats. 
 
2.10.2 Identification of Data Needs 
 
Acute-Duration Exposure. There is no information available to identify target organs in humans or 
animals following acute-duration inhalation or dermal exposure to di-n-octylphthalate. No 
information is available on the effects of acute-duration oral exposure to di-n-octylphthalate in humans. 
Therefore, the data are not sufficient to derive an acute inhalation MRL. An oral LD50 of di-n-
octylphthalate of 53,700 mg/kg has been reported for male rats (Dogra et al. 1987). An oral LD50 of 




intraperitoneal exposure (Dogra et al. 1985). The liver appears to be the target organ following acute-
duration oral exposure to di-n-octylphthalate, and an acute oral MRL of 3 mg/kg/day was calculated
based on increased relative liver weight and enzyme changes (Lake et al. 1986). Gross and
microscopic changes in the liver were observed in rats fed di-n-octylphthalate for 10 days (Mann et al.
1985). Decreased thyroxine levels and ultrastructural changes in the thyroid were noted in rats fed di-n-
octylphthalate in the diet (2,000 mg/kg/day) for 3 days in the Mann et al. (1985) study (Hinton et al.
1986).
The Mann et al. (1985) study is limited in that too few animals were used, organs other than the liver
were not adequately evaluated, and only males were studied. Although an adequate acute-duration oral
study would be useful to corroborate or refute the thyroid effects seen in the Mann et al. (1985) study,
this does not represent a data need, since an acute oral MRL has been derived. Ingestion of contaminated
drinking water is expected to be the predominant route of exposure for individuals living in the
vicinity of hazardous waste sites. However, acute-duration inhalation and dermal studies in animals
are needed to assess the potential toxicity of di-n-octylphthalate following exposure via these routes
because there are insufficient pharmacokinetic data available to support the extrapolation of data
obtained after oral administration to other routes of exposure.
Intermediate-Duration Exposure. There is no information available to identify target organs in
humans or animals following intermediate-duration inhalation or dermal exposure to di-n-octylphthalate.
Therefore, the data are not sufficient to derive an intermediate-duration inhalation
MRL. No information is available on the effects of intermediate-duration oral exposure to di-n-
octylphthalate in humans. The liver appears to be the target organ following intermediate-duration oral
exposure to di-n-octylphthalate (DeAngelo et al. 1986; Mann et al. 1985; Poon et al. 1995). An
intermediate-duration oral MRL of 0.4 mg/kg/day was calculated based on increases in hepatic
ethoxyresorufin-O-deethylase activity and histopathological changes in the liver of rats (Poon et al.
1995). Mild microscopic changes were also noted in the thyroid in this study (Poon et al. 1995).
Effects on the thyroid (decreased thyroxine levels, reduction in follicle size and colloid density, and
ultrastructural changes) have been reported in rats fed diets containing di-n-octylphthalate for 21 days
in the Mann et al. (1985) study (Hinton et al. 1986) or 13 weeks (Poon et al. 1995). Both the Mann
et al. (1985) and the DeAngelo et al. (1986) studies are limited in that too few animals were used,
organs other than the liver were not adequately evaluated, and only males were studied. Because
statistical analysis was not performed on the data in the Poon et al. (1995) study and the thyroid
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effects that were observed were mild, it is difficult to determine at which concentration the LOAEL for 
these particular effects occurred. Although ingestion of contaminated drinking water is expected to be 
the predominant route of exposure for individuals living in the vicinity of hazardous waste sites, 
intermediate-duration inhalation and dermal studies in animals are needed to assess the potential 
toxicity of di-n-octylphthalate following these routes of exposure because there are insufficient 
pharmacokinetic data available to support the extrapolation of data obtained after oral administration to 
other routes of exposure. 
 
Chronic-Duration Exposure and Cancer. There is no information available to identify target 
organs in humans following chronic-duration inhalation, oral, or dermal exposure to di-n-octylphthalate. 
Therefore, the data are not sufficient to derive a chronic-duration inhalation MRL. 
Chronic-duration oral toxicity studies using di-n-octylphthalate are needed to identify target organs and 
to establish the levels at which effects may occur. Oral studies are needed because ingestion of 
contaminated drinking water is expected to be the predominant route of exposure for individuals living 
in the vicinity of hazardous waste sites. 
 
No studies were located regarding cancer in humans or animals following inhalation or dermal 
exposure to di-n-octylphthalate, and no studies were located in humans following oral exposure to this 
compound. Rats exposed to di-n-octylphthalate in the diet for either 10 or 26 weeks following a 
single subcarcinogenic intraperitoneal injection of diethylnitrosamine and partial hepatectomy exhibited 
increases in GGT-positive liver foci that were not associated with a peroxisome proliferation (Carter et 
al. 1992; DeAngelo et al. 1986). These results suggest that di-n-octylphthalate may be effective in 
promoting preneoplastic lesions in the rat liver, probably by a mechanism that does not rely on 
peroxisome proliferation. An oral cancer bioassay would be useful to establish whether di-n-octylphthalate 
has the potential to be carcinogenic to humans. 
 
Genotoxicity. There is convincing evidence from microbial assays that di-n-octylphthalate is not a 
mutagen in S. typhimurium (Florin et al. 1980; Goodyear 1981a; Sato et al. 1994; Seed 1982; 
Shibamoto and Wei 1986; Zeiger et al. 1982, 1985) and does not induce DNA damage in E. coli 
(Goodyear 1981b). Although genetic toxicology testing, particularly in mammalian cell systems, is 
limited, the reported studies were well conducted and uniformly negative. It is, therefore, doubtful 
whether further investigation of these end points in other mammalian cell lines would alter the 
negative conclusions. Of greater importance, however, is the demonstrated lack of mutagenesis of the 
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rodent hepatocarcinogen, di(2-ethylhexyl)phthalate in a similar battery of in vitro tests. The inactivity
of this carcinogenic phthalate suggests that in vitro genetic toxicology assays may have limited value
for predicting the carcinogenic potential of other phthalates such as di-n-octylphthalate. Nevertheless,
data from whole-animal studies using di-n-octylphthalate are needed since no literature exists on
potential adverse genetic effects in vivo.
Reproductive Toxicity. No studies were located regarding reproductive effects in humans or
animals following inhalation or dermal exposure to di-n-octylphthalate. No studies were located in
humans following oral exposure to this compound. Di-n-octylphthalate caused significant decreases in
human sperm motility in vitro (Fredricsson et al. 1993). The results of several acute- and
intermediate-duration oral studies in rodents indicate that the potential of di-n-octylphthalate to cause
adverse reproductive effects is low. Unlike other phthalate esters such as di(2-ethylhexyl)phthalate, di-n-
octylphthalate does not appear to adversely affect testicular function or morphology (Foster et al.
1980; Gray and Butterworth 1980; Heindel et al. 1989; Morrissey et al. 1989; NTP 1985; Oishi 1990;
Oishi and Hiraga 1980; Poon et al. 1995). However, some ultrastructural alterations in Leydig cells,
including vesiculation of the smooth endoplasmic reticulum, were noted in rats administered di-n-
octylphthalate by gavage on 2 consecutive days (Jones et al. 1993). Leydig cells obtained from rats
that were cultured and stimulated by LH to measure cellular integrity by examining testosterone output
showed decreased testosterone production when incubated with mono-n-octylphthalate, the major
metabolite of di-n-octylphthalate (Jones et al. 1993). Examination of these cells exposed in vitro
showed that mono-n-octylphthalate caused ultrastructural changes in several organelles, including the
smooth endoplasmic reticulum dilatation and mitochondrial degeneration. No adverse effects on the
female estrous cycle or on any index of reproductive function were seen in a multigeneration study in
mice (Heindel et al. 1989; Morrissey et al. 1989; NTP 1985). Although it is fairly well established
that di-n-octylphthalate does not induce adverse effects on male reproductive organs or reproductive
performance in either males or females, data on reproductive organ pathology, including ultra-structural
pathology, are needed in any 90-day studies that may be conducted with di-n-octylphthalate.
Developmental Toxicity. No studies were located regarding developmental effects in humans or
animals following inhalation or dermal exposure to di-n-octylphthalate, and no studies were located in
humans following oral exposure to this compound. The results of two oral studies in mice (one being
a multigeneration reproductive toxicity study) indicate that di-n-octylphthalate has a very low potential
to induce adverse developmental effects, especially in view of the very high doses that were evaluated
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in these studies (Hardin et al. 1987; Heindel et al. 1989; Morrissey et al. 1989; NIOSH 1983; NTP 
1985). No statistically significant and/or biologically significant effects were observed with respect 
either to embryo or fetal survival or growth, or to the incidence of skeletal or visceral malformations 
in offspring exposed in utero. However, a significant decrease in average fetal weight and a 
significantly increased incidence in gross fetal malformations were observed in the offspring of rats 
administered 4,890 mg/kg/day of di-n-octylphthalate by intraperitoneal injection (Singh et al. 1972). 
However, the effects seen following high-dose parenteral administration may not be relevant to human 
exposure. Well-conducted oral developmental toxicity studies in animals are needed to determine 
whether the negative results obtained in the two studies discussed above (one being a screen and the 
other being a multigeneration reproductive toxicity study not designed specifically to assess 
developmental toxicity) are valid, or if the effects seen after intraperitoneal administration of high 
doses of di-n-octylphthalate are likely to occur after oral administration. There are insufficient 
pharmacokinetic data available to support the extrapolation of data obtained after oral administration to 
other routes of exposure. However, oral studies would be the most useful since ingestion of 
contaminated drinking water is expected to be the predominant route of exposure for individuals living 
in the vicinity of hazardous waste sites. 
 
Immunotoxicity. No studies were located regarding immunological effects in humans or animals 
following inhalation or dermal exposure to di-n-octylphthalate, or in humans following oral exposure 
to this compound. Limited data in rats or mice suggest that di-n-octylphthalate can exert immunotoxic 
effects following acute oral or parenteral exposure to relative high doses. These effects are reflected in 
changes in the weight and morphology of various lymphoreticular organs (thymus, spleen, and lymph 
nodes), altered activity of humoral antibody-forming cells and cellular mediators of immunity, and 
reduced resistance to bacterial, viral, protozoan, or other parasitic infection (Dogra et al. 1985, 1987, 
1989). Additional data are needed to measure lymphoreticular organs and blood components of the 
immune system in any 90-day study that may be conducted with di-n-octylphthalate because the 
limited information available from animal studies suggests that this compound may exert immunotoxic 
effects.  
 
Neurotoxicity. No information is available on the neurological effects of di-n-octylphthalate in 
humans or animals following inhalation or dermal exposure or in humans following oral exposure. No 
clinical signs of neurotoxicity were noted in acute and intermediate duration dietary exposure studies 
using mice (Heindel et al. 1989; NTP 1985). Although these data are limited, it is not believed that 
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the low-level exposure to di-n-octylphthalate that occurs at hazardous waste sites will result in 
neurotoxicity. Because there is no information to suggest that the central nervous system is a target of 
di-n-octylphthalate, no additional information is needed at this time. 
 
Epidemiological and Human Dosimetry Studies. No epidemiological studies are available on 
populations that have been exposed solely to di-n-octylphthalate. As a result of its use, together with other 
phthalate esters, as a plasticizer in the production of polyvinyl chloride (PVC) resins and cellulose ester 
and polystyrene resins (EPA 1993a; HSDB 1995; Mannsville Chemical Products 
Corporation 1989) exposure of the general population and of workers in occupational settings is 
significant. Therefore, it is unlikely that both a specific subpopulation exposed only to di-n-octylphthalate 
and a control population with no known exposure could be identified. However, if 
suitable subpopulations could be found, then a well-conducted and controlled epidemiological study is 
needed to determine the potential target organs of di-n-octylphthalate toxicity in humans and the levels 
at which effects might be expected to occur. In addition, individuals at risk in the vicinity of 
hazardous waste sites could be identified and monitored. 
 
Biomarkers of Exposure and Effect 
 
Exposure. The monoester derivatives of di-n-octylphthalate and mono-n-octylphthalate or the 
oxidation products of mono-n-otylphthalates could potentially be used as a biomarker of exposure; 
however, only a few studies have been located that measure these metabolites in body tissues or fluids 
following exposure to di-n-octylphthalate (Albro and Moore 1974; Oishi 1990). Studies that 
investigate the fate and/or elimination of these metabolites are needed to determine its value as a 
biomarker of exposure for di-n-octylphthalate. Additional information on the metabolism of di-n-
octylphthalate could help identify other potential biomarkers of exposure. 
 
Effect. Since exposure to di-n-octylphthalate does not produce a unique clinical disease state, no 
biomarkers of effect have been identified. Additional information on the potential health effects of di-n-
octylphthalate is needed to identify biomarkers of exposure to this compound. 
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Absorption, Distribution, Metabolism, and Excretion. No studies were located regarding the
absorption of di-n-octylphthalate in humans and animals following inhalation and dermal exposure.
Information on absorption in humans following oral exposure is not available. There are studies
that suggest oral absorption of di-n-octylphthalate occurs in animals (Albro and Moore 1974; Oishi 1990;
Poon et al. 1995); however, quantitative information is lacking. Additional information, primarily
quantitative data, on absorption of di-n-octylphthalate for all routes of exposure is needed to
understand and predict effects.
Information on the distribution of di-n-octylphthalate is limited to oral studies in rats, one by Oishi
(1990), which reported the identification of mono-n-octylphthalate in blood and testes with peak levels
observed at 3 hours for blood and at 6 hours for testes after dosing, and the other by Poon et al.
(1995), which reported di-n-octylphthalate in the liver that was either below or slightly above detection
limits; higher levels (15-25 ppm) of residue were also found in adipose tissue. However, this latter
study was limited because metabolite levels were not measured. The metabolism of di-n-octylphthalate
following acute exposure has been studied in animals in vivo and in vitro (Albro and
Moore 1974; Brodsky et al. 1986; Lake et al. 1977). Metabolism studies following longer term
exposures are needed in order to determine if metabolic pathways become saturated or altered.
Although the Albro and Moore (1974) study seems to indicate that urine is the major elimination route
of di-n-octylphthalate, additional excretion studies are needed to provide quantitative information.
Additional studies on the mechanism involved in absorption and distribution of the compound are
needed to provide information on how to increase elimination of the compound from the body.
Comparative Toxicokinetics. Based on the rat study by Albro and Moore (1974), di-n-octylphthalate
appears to be readily absorbed following oral administration, metabolized extensively,
and excreted primarily in the urine. Because of the lack of human data and limited animal data on the
absorption, distribution, metabolism, and excretion of di-n-octylphthalate, additional studies are needed
in order to make comparisons on the toxicokinetics across species.
Methods for Reducing Toxic Effects. All of the treatment methods currently available for use
in di-n-octylphthalate ingestion or skin contact are supportive in nature and/or involve decreasing the
absorption or increasing the rate of elimination of di-n-octylphthalate (Stutz and Ulin 1992). Since the
mechanism of di-n-octylphthalate toxicity is not known, there are currently no methods that focus on
mitigating the effects of di-n-octylphthalate by interfering with its mode of action. Therefore, more
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information on the mechanism of action for di-n-octylphthalate is needed in order to devise methods 
for the mitigation of its toxic effects. 
 
 
2.10.3 On-going Studies 
 
No on-going studies on the health effects or toxicokinetics of di-n-octylphthalate were found. 





3. CHEMICAL AND PHYSICAL INFORMATION 
 
 
3.1 CHEMICAL IDENTITY 
 
Information regarding the chemical identity of di-n-octylphthalate is located in Table 3-l. 
 
3.2 PHYSICAL AND CHEMICAL PROPERTIES 
 
Information regarding the chemical and physical properties of di-n-octylphthalate is located in 
Table 3-2. 
 
There is conflicting information for many of these properties in the literature. A possible explanation 
for the inconsistencies, as discussed in Chapter 2, may come from the use of the nonspecific term “di-
octylphthalate.” This conflict has contributed to significant confusion and misinformation in the 
literature with respect to di-n-octylphthalate and the much more common isomer, di(2- 
ethylhexyl)phthalate. Although frequently being interpreted as referring to di-n-octylphthalate, it is 
apparent that in almost all cases “di-octylphthalate” and “DOP” have in fact been used as synonyms 
for di(2-ethylhexyl)phthalate. Therefore, many of the properties found for di-n-octylphthalate or di-
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Di-n-octylphthalate is produced commercially as a component of mixed phthalate esters, including 
straight- chain C6, C8, and Cl0 phthalates (EPA 1993a). Di-n-octylphthalate is produced at 
atmospheric pressure or in a vacuum by heating an excess of n-octanol with phthalic anhydride in the 
presence of an esterification catalyst such as sulfuric acid or p-toluenesulfonic acid. The process may 
be either continuous or discontinuous (EPA 1993a; HSDB 1995). Di-n-octylphthalate can also be 
produced by the reaction of n-octylbromide with phthalic anhydride. 
 
The most recent report available on di-n-octylphthalate lists three commercial producers: Vista 
Chemical Company, Houston, Texas; Aristech Chemical Corporation, Neville Island, Pennsylvania; 
and Teknor Apex Company, Hebronville, Massachusetts and Brownsville, Texas (EPA 1993a). 
Additional reported producers include: Eastman Kodak Company, Rochester, New York (USITC 
1994); Tenneco Chemical, Inc., Chestertown, Maryland (EPA 1987a); Alfa Products, Morton Thiokol, 
Inc., Danvers, Massachusetts; Primachem, Inc., Englewood Cliffs, New Jersey; and GCA Chemical 
Corp., Stamford, Connecticut (HSDB 1995). Table 4-1 lists the U.S. facilities that manufacture or 
process di-n-octylphthalate. 
 
The current annual production of di-n-octylphthalate is difficult to estimate because of confusion in 
nomenclature regarding the octylphthalate isomers and reported data describing only the entire group 
of dioctyl orthophthalates. A total of 122,384 metric tons of total dioctylphthalates were produced in 
1992 (USITC 1994). The amount of di-n-octylphthalate included in this group was not reported 
because of the possible revelation of confidential business information. 
 
Table 4-l lists data from the Toxics Release Inventory (TRI) regarding U.S. companies that reported 
the manufacture and use of di-n-octylphthalate in 1992 (TR192 1994). The TRI data should be used 
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In 1988, 6 million pounds of di-octylphthalates (i.e., di-n-octylphthalate and di[2-ethylhexyl]phthalate) 
were imported and 37 million pounds were exported. No data were located on specific quantities for 




Di-n-octylphthalate is principally used as a plasticizer in the production of plastics (Sittig 1991) and 
PVC resins. When used as a plasticizer, di-n-octylphthalate can represent 5-60% of the total weight 
of the plastics and resins. It increases flexibility and enhances or alters the properties of the material. 
It is also used for cellulose ester and polystyrene resins, as a dye carrier in plastic production 
(primarily PVC), and as a chemical intermediate in the manufacture of adhesives, plastisols, and 
nitrocellulose lacquer coatings (EPA 1993a; HSDB 1995; Mannsville Chemical Products Corporation 
1989). It is a registered active ingredient in pesticides (EPA 1987b) and is found in cosmetics and 
colorants (EPA 1992a). Di-n-octylphthalate also serves as a carrier for catalysts or initiators and as a 
substitute for electrical capacitor fluid (EPA 1992a). 
 
Flexible PVC resins and other dioctylphthalate-containing plastics and resins are used in a variety of 
industrial and domestic products: plastisols for carpetback coating (EPA 1987b), film, wire, cables, 
and adhesives (HSDB 1995). Additional end-use products are automobile and furniture upholstery, 
wall coverings, window shades, garden hoses, shower curtains, tablecloths, rainwear, shoes, dolls, and 




Di-n-octylphthalate, including waste containing di-n-octylphthalate, is classified as a hazardous waste 
product by EPA. Generators of waste containing this contaminant must conform to EPA regulations 
for treatment, storage, and disposal (see Chapter 7). Rotary kiln or fluidized bed incineration methods 
are acceptable disposal methods for these wastes. Liquid injection incineration may also be used 
(HSDB 1995). 
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According to the TRI, 240,609 pounds of di-n-octylphthalate were transferred to landfills and/or 
treatment/disposal facilities in 1992 (see Section 5.2) (TR192 1994). Of this quantity, about 
1,475 pounds were discharged to publicly owned treatment works. A total of 15,302 pounds was 
released to air, land, and water by manufacturing and processing facilities. No di-n-octylphthalate was 
released for underground injection. 
DI-n-OCTYLPHTHALATE  75
5. POTENTIAL FOR HUMAN EXPOSURE
5.1 OVERVIEW
Di-n-octylphthalate is released mainly to the atmosphere and to some extent to surface waters in
industrial effluents (TRI92 1994). The compound may be released to soils in the disposal of plastics
wastes. Di-n-octylphthalate is expected to partition mainly to soils and sediment upon release to the
environment (EPA 1979, 1992c). The compound is also bioconcentrated by aquatic organisms,
although biomagnification in aquatic food chains is not expected to be significant (EPA 1992d).
Aerobic biodegradation is the most important transformation process in soils and surface waters (EPA
1992a, 1992c). Other transformation processes include photooxidation in the atmosphere and
photolysis in surface waters (EPA 1992a). As a result of confusion with its branched isomer, di(2-
ethylhexyl)phthalate, limited unambiguous monitoring data are available for di-n-octylphthalate. The
compound has been detected in ambient air, rain, runoff, groundwater, surface water, and sediment.
Human exposure to the compound is expected to occur primarily in workplace settings (HSDB 1995).
General population exposure pathways include inhalation of the volatilized plasticizer, ingestion of
foods contaminated as a result of leaching of di-n-octylphthalate from plastic containers, ingestion of
aquatic organisms that have bioconcentrated the compound, and ingestion of contaminated drinking
water (EPA 1992c). Populations living near hazardous waste sites contaminated with di-n-octylphthalate
may also be exposed through dermal contact with and ingestion of contaminated
groundwater and sediments (ATSDR 1988, 1989b, 1989c). Populations with potentially high
exposures to di-n-octylphthalate include workers in the chemical manufacturing and plastics
manufacturing and processing industries, individuals requiring routine medical care, such as blood
transfusions and kidney dialysis treatments, and individuals living in the vicinity of industrial
manufacturing and processing facilities that may manufacture or use di-n-octylphthalate or of
hazardous waste sites containing di-n-octylphthalate or plastics (HSDB 1995).
Di-n-octylphthalate has been identified in at least 300 of the 1,416 hazardous waste sites on the EPA
National Priorities List (NPL) (HazDat 1995). However, the number of sites evaluated for di-n-
octylphthalate is not known. The frequency of these sites within the United States can be seen in
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Figure 5-1. Of these sites, 298 are located in the United States and 2 are located in the
Commonwealth of Puerto Rico (not shown).
5.2 RELEASES TO THE ENVIRONMENT
Considerable confusion exists in the literature about the TRI release reporting data and monitoring data
available for di-n-octylphthalate and its more common branched isomer, di(2-ethylhexyl)phthalate
(EPA 1992a; Vista Chemical 1992). The confusion exists because the terms “dioctyl phthalate” and
“DOP” are often used as synonyms for di(2-ethylhexyl)phthalate, which is the largest volume
plasticizer used in PVC. Consequently, some of the historical release and monitoring data reported in
the literature as “dioctyl phthalate” and “DOP” refer to the more common branched isomer rather than
di-n-octylphthalate. Therefore, releases of di-n-octylphthalate and concentrations of the compound in
ambient media may actually be lower than historical data suggest. Di-n-octylphthalate was withdrawn
from the TRI effective in 1993 (EPA 1995h). Thus, the data for TRI92 (1994) is the most recent data
that is available from the Toxic Release Inventory for di-n-octylphthalate.
5.2.1 Air
Di-n-octylphthalate may be released to the atmosphere through volatilization of the compound from
plastics, as a result of manufacturing processes, and through incineration (Vista Chemical 1992).
According to TR192 (1994), an estimated total of 15,011 pounds of di-n-octylphthalate, amounting to
about 98% of the total environmental release, were discharged to the atmosphere from manufacturing
and processing facilities in the United States in 1992 (see Table 5-l). The TRI data listed in
Table 5-l should be used with caution since only certain types of facilities are required to report. This
is not an exhaustive list. Furthermore, as noted above, the precise chemical identity of the reported
releases is questionable.
5.2.2 Water
Di-n-octylphthalate is released to surface waters in industrial waste waters from production and use
processes and as a result of spills during its transport, storage, and use (Mathur 1974a). For example,
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concentration of 3,700 µg/L (EPA 1981). Releases to surface waters are expected to undergo
secondary treatment at publicly owned treatment works or at on-site National Pollutant Discharge
Elimination System (NPDES) permitted facilities. Such waste-water treatment systems are expected to
remove 80-90% of the influent di-n-octylphthalate through a combination of adsorption and aerobic
biodegradation by acclimated microorganisms (EPA 1992c Petrasek et al. 1983). The compound is
also released to surface waters from nonpoint sources, such as surface runoff. For example, di-n-
octylphthalate was found in runoff samples collected in 1982 from Little Rock, Arkansas, Bellevue,
Washington, and Eugene, Oregon, at a 4% frequency of detection in the collected samples and at
concentrations of 0.4-l µg/L. This sampling was conducted as part of the Nationwide Urban Runoff
Program (Cole et al. 1984).
According to TR192 (1994), an estimated total of 41 pounds of di-n-octylphthalate were discharged to
surface waters from manufacturing and processing facilities in the United States in 1992 (see
Table 5-l). An estimated total additional 1,475 pounds were transferred to publicly owned treatment
works. The TRI data listed in Table 5-l should be used with caution since only certain types of
facilities are required to report. This is not an exhaustive list. Furthermore, as noted above, the
precise chemical identity of the reported releases is questionable.
5.2.3 Soil
According to TR192 (1994), an estimated total of 250 pounds of di-n-octylphthalate, amounting to
about 2% of the total environmental release, was discharged to soils from manufacturing and
processing facilities in the United States in 1992 (see Table 5-l). An estimated total additional
239,134 pounds were transferred to off-site waste treatment, storage, and disposal facilities. The TRI
data listed in Table 5-l should be used with caution since only certain types of facilities are required
to report. This is not an exhaustive list. Furthermore, as noted above, the precise chemical identity of
the reported releases is questionable.
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5.3 ENVIRONMENTAL FATE 
 
5.3.1 Transport and Partitioning 
 
Upon release to surface waters, di-n-octylphthalate is expected to partition mainly to sediments and to 
suspended particulates. In a pilot-scale waste-water treatment system, di-n-octylphthalate partitioned 
mainly to primary treatment sludge (Petrasek et al. 1983). The compound strongly adsorbs to organic 
matter contained in soils and sediments; adsorption is probably the most important transport process 
for the compound in surface waters (EPA 1979, 1992c). Volatilization from surface waters is expected 
to be a slow and unimportant process. For example, the estimated volatilization half-life from a model 
river 1 meter deep with a current of 1 meter/second and a wind speed of 3 meters/second is 13 days 
(HSDB 1995). In a pilot-scale study of a typical waste-water treatment plant employing both primary 
and secondary activated sludge treatment processes, no di-n-octylphthalate was lost from the system by 
air stripping (Petrasek et al. 1983). However, in a study simulating the behavior of di-n-octylphthalate 
in different aquatic systems, volatilization was estimated to account for up to 20% of the losses of the 
compound from certain standing surface water systems characterized by long water detention times 
(e.g., ponds, lakes), especially in relatively pristine lakes where loss by biodegradation is not likely to 
be important (Wolfe et al. 1980). This same study suggests that in running surface waters, such as 
rivers, di-n-octylphthalate is most likely to be lost by transport out of the system. 
 
Di-n-octylphthalate also strongly adsorbs to soils and does not undergo leaching to groundwater, as 
indicated by its estimated soil organic carbon/water partition coefficient (Koc) of about 19,000. 
Volatilization from soils is not expected to be significant (HSDB 1994; Vista Chemical 1992). 
 
Di-n-octylphthalate released to the atmosphere may partition to soils and surface waters through wet 
(Ligocki et al. 1985) and dry (Vista Chemical 1992) deposition processes. 
 
Di-n-octylphthalate is bioconcentrated by aquatic organisms (EPA 1992d). In a 33-day combined 
terrestrial-aquatic model ecosystem study, the following di-n-octylphthalate bioconcentration factors 
(BCFs) were reported: (1) algae - 28,500; (2) daphnids - 2,600; (3) fish and mosquitoes - 9,400; and 
(4) snails - 13,600. However, the half-life for the disappearance of di-n-octylphthalate from this model 
system was estimated to be about 5 days as the result of metabolism of the compound. An EPA 
(1992d) hazard assessment stated that although di-n-octylphthalate does bioconcentrate in aquatic 
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organisms, the compound is not expected to biomagnify in aquatic food chains; however, this citation
did not contain, and does not reference any studies that provide, a basis for this conclusion. In
greenhouse studies using radiolabeled di-n-octylphthalate added to soils, the compound was not
bioconcentrated by crop plants (BCF <1) (EPA 1986e). In a more recent screening study that
examined the potential of contaminants contained in sewage sludge to transfer into agricultural
products on the basis of their physical/chemical properties, di-n-octylphthalate was judged to have a
high potential to adsorb to soil, sludge solids, and plant root surfaces, and a low potential for leaching,
uptake and translocation by plants, and transfer to animal tissues by foliage ingestion (Wild and Jones
1992).
5.3.2 Transformation and Degradation
5.3.2.1 Air
The most important transformation process for di-n-octylphthalate present in the atmosphere as an
aerosol is reaction with photochemically produced hydroxyl radicals. The half-life for this reaction has
been estimated to be 4.5-44.8 hours (Howard et al. 1991). Actual atmospheric half-lives may be
longer since phthalate esters sorbed to wind-entrained particulates may have long atmospheric
residence times (Vista Chemical 1992). Direct photolysis in the atmosphere is not expected to be an
important process (EPA 1993a; HSDB 1995).
5.3.2.2 Water
Phthalate esters undergo a step-wise alkaline hydrolysis to monoesters and then to dicarboxylic acids.
As a result of the relatively slow rates of this reaction at pH 6-9 and the low water solubility of di-n-
octylphthalate, chemical hydrolysis of the compound is not an environmentally important
transformation process (EPA 1992a). Hydrolytic half-lives at 25°C and pH 7 and 9 have been
estimated to be 107 and 7 years, respectively (Howard et al. 1991).
Biodegradation is the primary process by which phthalate esters are removed from surface waters;
rates are strongly dependent on acclimation of microbial communities (EPA 1992a, 1992~). Wolfe et
al. (1980) predicted that biodegradation would be the most important mechanism by which di-n-
octylphthalate would be removed from eutrophic lakes. In static culture flask biodegradation screening
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tests, about 93-94% of di-n-octylphthalate was metabolized after 3 weeks only after serial subculturing
of acclimated microorganisms (Tabak et al. 1981). Enzymatic hydrolysis is the mechanism used by
microbes in the aerobic biotransformation of di-n-octylphthalate. The ester is hydrolyzed to soluble
intermediates, presumably via a pathway producing a phthalic acid monoester (EPA 1993a); however,
data on the identity of biodegradation products were not available. Aerobic biodegradation half-lives
range from 1 to 4 weeks in surface waters and from 2 weeks to 1 year in groundwater (Howard et al.
1991). Biodegradation under anaerobic conditions occurs at a slower rate (EPA 1993a); it has been
predicted that di-n-octylphthalate will accumulate in natural sediments because it is persistent under
anaerobic conditions (EPA 1992d). For example, in anaerobic digester studies using diluted and
undiluted sewage treatment plant sludge, between 40% and 75% of di-n-octylphthalate remained
undegraded after a 10-week incubation period (Shelton et al. 1984). Anaerobic half-lives for aquatic
systems have been predicted to range from 6 months to 1 year (Howard et al. 1991).
Di-n-octylphthalate may also undergo photolysis in surface waters as a result of its absorption of
electromagnetic radiation at wavelengths less than 290 nm. The estimated photolytic half-life of the
compound in surface water is 144 days (EPA 1992a). Photolysis was predicted to be the most
important removal mechanism after volatilization for di-n-octylphthalate losses from oligotrophic lakes
(Wolfe et al. 1980).
5.3.2.3 Sediment and Soil
As discussed above, aerobic biotransformation is expected to be the most important process in the
removal of di-n-octylphthalate from soils; anaerobic biodegradation occurs in sediments (EPA 1992a).
However, because of its persistence under anaerobic conditions, di-n-octylphthalate is expected to
accumulate in sediments (EPA 1992d). Di-n-octylphthalate has been reported to undergo
biodegradation by a variety of acclimated soil microorganisms (HSDB 1995; Mathur 1974b); however,
data on the identity of biodegradation products were not located.
5.4 LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT
As previously discussed, considerable confusion exists in the literature about the monitoring data
available for di-n-octylphthalate and di(2-ethylhexyl)phthalate. Only monitoring data that clearly
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concerned di-n-octylphthalate were included in this section of the profile; data from ambiguous studies
were not included.
5.4.1 Air
Di-n-octylphthalate was detected in five of seven ambient air and six of seven rainwater samples
collected during rain events that occurred in February through April 1984 in Portland, Oregon. Di-n-
octylphthalate concentrations ranged from 2.6 to 20 ng/L in rain samples and from 0.06 to 0.94 ng/m3
in air samples (Ligocki et al 1985).
5.4.2 Water
Di-n-octylphthalate was detected in 4% of the urban runoff samples collected from a total of 15 cities.
Di-n-octylphthalate was detected at three cities at concentrations of 0.4-l µg/L (Cole et al. 1984). The
compound was found in water samples collected at four locations along the entire length of the
Mississippi River at concentrations of 24-310 ng/L (DeLeon et al. 1986). At the Butler Mine Tunnel
NPL Site located in Pittston, Pennsylvania, di-n-octylphthalate was detected in on-site oil/groundwater
samples at concentrations of ll0-792,000 ppb (ATSDR 1989b). Di-n-octylphthalate was detected at a
concentration of 1 ppb in a water sample collected from the discharge pond of a phthalate ester plant
located on the Chester River in Maryland (Peterson and Freeman 1984). Di-n-octylphthalate was
found at 0.001-0.02 ppm in water samples taken from a river that received industrial waste water from
a specialty chemical manufacturing plant (Jungclaus et al. 1978).
Estimates of di-n-octylphthalate concentrations in receiving waters located downstream from two plants
reporting releases of the compound to the TRI have been developed by EPA (1992c). Mean flow
concentrations of about 3-9 µg/L and 7-year Ql0 low-flow concentrations of about 90-390 µg/L were
estimated for the surface waters receiving effluent from the on-site treatment facility used at one plant
and the publicly owned treatment facility that handles the effluent from the other plant.
Concentrations of di-n-octylphthalate in drinking water utility influents have been estimated to be less
than 0.5 ppb (EPA 1992c).
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5.4.3 Sediment and Soil 
 
In the sediment of a discharge pond of a phthalate ester plant located on the Chester River in 
Maryland, di-n-octylphthalate was detected at a concentration of 12,000 ppb. In sediment samples 
from the Chester River taken 2 km and 8 km downstream from the plant, the compound was found at 
concentrations of 62 and <5 ppb, respectively (Peterson and Freeman 1984). In the sediment of a 
river that received industrial waste water from a specialty chemical manufacturing plant, di-n-
octylphthalate was detected at concentrations ranging from 1.5 to 25 ppm (Jungclaus et al. 1978). At 
the Dixie Caverns Landfill NPL site located in Salem, Virginia, di-n-octylphthalate was detected on-site at 
a concentration of 80 ppm (ATSDR 1988); however, the media in which this concentration was 
detected was not specified. Off-site sediment samples collected at the Revere Chemical Company 
NPL site located in Revere, Pennsylvania, were found to contain 2,300 ppb di-n-octylphthalate 
(ATSDR 1989c). 
 
EPA (1992c) developed estimates of di-n-octylphthalate concentrations in the sediments of surface 
waters located downstream from two plants reporting releases of the compound to the TRI. The 
surface waters received effluents from an on-site treatment facility and a publicly owned treatment 
facility. Steady-state sediment concentrations were estimated to exceed 10 mg/kg and possibly 
>50 mg/kg downstream from the two facilities. 
 
5.4.4 Other Environmental Media 
 
Di-n-octylphthalate is produced as a decomposition product of the pesticide dinocap (HSDB 1995). 
 
5.5 GENERAL POPULATION AND OCCUPATIONAL EXPOSURE 
 
Humans are expected to be exposed to di-n-octylphthalate mainly in the workplace (HSDB 1994). 
The National Occupational Exposure Survey (NOES), conducted between 1981 and 1983; estimated 
that 10,393 workers (including 1,434 women) in 1,177 facilities were exposed to di-n-octylphthalate in 
the workplace in 1980 (NIOSH 1993). 
 
Exposure of the general population to di-n-octylphthalate may occur through ingestion of foods 
contaminated by leaching of the compound from plastic containers, transfusions of blood or other 
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fluids through medical tubing, ingestion of aquatic organisms that have bioconcentrated the compound,
and consumption of contaminated drinking water (EPA 1992c; HSDB 1995). An additional potential
source of human exposure is contact with contaminated media at hazardous waste sites. For example,
di-n-octylphthalate has been detected in on-site sediment and groundwater samples and off-site
sediment samples collected at NPL hazardous waste sites. The human exposure pathways of concern
at these sites include ingestion of contaminated groundwater and sediment (ATSDR 1988, 1989b,
1989c). Since data are not available on the dermal absorption of di-n-octylphthalate, it is not known
whether dermal contact with di-n-octylphthalate at hazardous waste sites would represent an exposure
pathway of concern.
In an early report of the 1982 annual results of the National Human Adipose Tissue Survey (NHATS),
a compound identified as di-n-octylphthalate was reportedly detected in 31% of the composite human
adipose tissue samples taken in the various regions of the United States that year. Concentrations in
lipid ranged from below the level of detection (9 ng/sample) to a maximum of 850 ng/g (EPA 1986d).
However, a later report of the 1982 results stated that the chemical detected was not di-n-octylphthalate,
but was actually diethylhexyl phthalate (EPA 1989b).
5.6 POPULATIONS WITH POTENTIALLY HIGH EXPOSURES
Patients receiving regular dialysis on a kidney machine or receiving blood transfusions may be the
populations with the highest potential exposure to di-n-octylphthalate. Workers in industries that
produce or use plastics, especially materials processed at high temperatures, are also expected to have
potentially high exposure to di-n-octylphthalate especially via inhalation of the volatilized plasticizer.
Members of the general population living in the vicinity of industrial facilities that manufacture or
process the compound or plastic materials containing the compound, as well as individuals living near
hazardous waste sites known to be contaminated with di-n-octylphthalate, are also expected to have
potentially high exposures through contact with contaminated environmental media (HSDB 1995).
5.7 ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with
the Administrator of EPA and agencies and programs of the Public Health Service) to assess whether
adequate information on the health effects of di-n-octylphthalate is available. Where adequate
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information is not available, ATSDR, in conjunction with the NTP, is required to assure the initiation 
of a program of research designed to determine the health effects (and techniques for developing 
methods to determine such health effects) of di-n-octylphthalate. 
 
The following categories of possible data needs have been identified by a joint team of scientists from 
ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that if met would 
reduce the uncertainties of human health assessment. This definition should not be interpreted to mean 
that all data needs discussed in this section must be filled. In the future, the identified data needs will 
be evaluated and prioritized, and a substance-specific research agenda will be proposed. 
 
5.7.1 Identification of Data Needs 
 
Physical and Chemical Properties. The physical and chemical properties of di-n-octylphthalate are 
sufficiently well defined to allow assessments of the environmental fate of the  
compound to be made. Therefore, no additional information is needed a this time. 
 
Production, Import/Export, Use, Release, and Disposal. Because of the general  
confusion in the literature about the nomenclature for octylphthalate esters, historical information about 
the production and import/export of di-n-octylphthalate is not readily available. These values generally 
must be estimated as a percentage of di(2-ethylhexyl)phthalate production or import/export. The 
compound is used principally as a plasticizer additive to plastics and PVC resins. It is also used as a 
dye carrier in plastics production and as a chemical intermediate (EPA 1993a; HSDB 1995; Mannsville 
Chemical Products Corporation 1989; Sittig 1991). Limited information is available about releases of 
di-n-octylphthalate to environmental media. Even the TRI data, which comprise the most current 
information available, contain errors as a result of the nomenclature confusion (EPA 1993a; Vista 
Chemical 1992). Data are available about the disposal and regulatory status of the compound (see 
Chapters 4 and 7). More information on the production and releases of di-n-octylphthalate is needed 
to estimate potential exposure to the compound. 
 
According to the Emergency Planning and Community Right-to-Know Act of 1986, 42 U.S.C. Section 
11023, industries are required to submit substance release and off-site transfer information to the EPA. 
The Toxics Release Inventory (TRI), which contains this information for 1993, became available in 
May of 1995. This database will be updated yearly and should provide a list of industrial production 
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facilities and emissions. However, di-n-octylphthalate was withdrawn from the TRI effective in 1993 
(EPA 1995h). 
 
Environmental Fate. Di-n-octylphthalate partitions primarily to soils and sediment upon release to 
the environment. The compound is expected to be strongly sorbed to soil and sediment particulates; 
therefore, it should have limited mobility (EPA 1979, 1992c). Biodegradation half-lives of l-4 weeks 
have been estimated for aerobic surface waters and soils. Biodegradation also takes place in 
sediments; half-lives under anaerobic conditions have been estimated to range from of 6 months to 
1 year (Howard et al. 1991). The compound may also undergo photolysis in surface waters (estimated 
half-life of 144 days) and photooxidation in the atmosphere (estimated half-life of about 5-45 hours) 
(Howard et al. 1991). Di-n-octylphthalate may persist in sediments as a result of its limited rate of 
biotransformation and preferential partitioning to this medium. 
 
However, although degradation is known to occur under both aerobic and anaerobic conditions, data 
are not available on the identity of degradation products. Because the limited studies on the 
mechanisms of injury from di-n-octylphthalate suggest that mono-n-octylphthalate is the proximate 
toxicant, it is important to know whether the reduction of di-n-octylphthalate is coupled with the 
accumulation of mono-n-octylphthalate. The environmental fate of di-n-octylphthalate and its 
metabolites is not sufficiently understood to allow assessments of its exposure potential to be made. 
Additional data are needed on the identify and fate of degradation products of di-n-octylphthalate. No 
additional information is needed about the transport and partitioning of the compound at this time. 
 
Bioavailability from Environmental Media. No information was found regarding the  
absorption of di-n-octylphthalate by humans or laboratory animals following inhalation or dermal  
exposures. No information is available about absorption following oral exposure in humans. However,  
indirect evidence from animal studies suggests that the compound is readily absorbed by this route (Albro  
and Moore 1974; Oishi 1990). Additional information is needed on the absorption of di-n-octylphthalate 
as a result of inhalation of contaminated air, ingestion of contaminated food and water, and dermal 
contact with contaminated soils and sediments. 
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Food Chain Bioaccumulation. Di-n-octylphthalate bioconcentrates in aquatic organisms. 
However, as a result of metabolism of the compound, biomagnification in aquatic food chains does not 
occur (EPA 1992d). It appears that the compound is not bioconcentrated by terrestrial plants or 
animals or biomagnified in terrestrial food chains (EPA 1986e; Wild and Jones 1992). However, the 
Wild and Jones (1992) study is limited to mathematical modeling results. Thus, only limited data are 
available regarding the bioaccumulation and biomagnification of di-n-octylphthalate, and the potential 
for human exposure resulting from the bioaccumulation of the compound is not well understood. 
Therefore, additional data are needed to validate the Wild and Jones (1992) model. Also, an 
estimation of animal uptake from soil ingestion is needed to support this study. 
 
Exposure Levels in Environmental Media. Reliable monitoring data for the levels of di-n-
octylphthalate in contaminated media at hazardous waste sites are needed so that the information 
obtained on levels of di-n-octylphthalate in the environment can be used in combination with the 
known body burden of di-n-octylphthalate to assess the potential risk of adverse health effects in 
populations living in the vicinity of hazardous waste sites. Di-n-octylphthalate has been detected in 
ambient air, rain, surface water, groundwater, and sediment. However, as a result of the confusion 
about the nomenclature for octylphthalate esters, much of the historical monitoring data available 
actually pertain to the branched isomer, di(2-ethylhexyl)phthalate (Vista Chemical 1992). Therefore, 
little current information specific to the n-octyl isomer is available regarding concentrations of the 
compound in foods, drinking water, and environmental media, particularly with respect to media at 
hazardous waste sites. The lack of monitoring data precludes the estimation of human exposure via 
intake of or contact with contaminated media. 
 
Exposure Levels in Humans. This information is necessary for assessing the need to conduct 
health studies on these populations. Di-n-octylphthalate has historically been reported to have been 
found in human adipose tissue (EPA 1986d). However, more recent information indicates that the 
compound detected was actually the branched di(Zethylhexy1) isomer (EPA 1989b). Additional 
information on the concentrations of di-n-octylphthalate in human tissues and fluids, parficularly for 
populations living near hazardous waste sites, is needed to assess potential human exposure to the 
compound. 
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Exposure Registries. No exposure registries for di-n-octylphthalate were located. This substance 
is not currently one of the compounds for which a subregistry has been established in the National 
Exposure Registry. The substance will be considered in the future when chemical selection is made 
for subregistries to be established. The information that is amassed in the National Exposure Registry 
facilitates the epidemiological research needed to assess adverse health outcomes that may be related 
to exposure to this substance. 
 
5.7.2 On-going Studies 
 
No information was found in the available literature concerning on-going studies dealing with the 
environmental fate or human exposure potential of di-n-octylphthalate. 





6. ANALYTICAL METHODS 
 
 
The purpose of this chapter is to describe the analytical methods that are available for detecting, and/or 
measuring, and/or monitoring di-n-octylphthalate, its metabolites, and other biomarkers of exposure 
and effect to di-n-octylphthalate. The intent is not to provide an exhaustive list of analytical methods. 
Rather, the intention is to identify well-established methods that are used as the standard methods of 
analysis. Many of the analytical methods used for environmental samples are the methods approved 
by federal agencies and organizations such as EPA and the National Institute for Occupational Safety 
and Health (NIOSH). Other methods presented in this chapter are those that are approved by groups 
such as the Association of Official Analytical Chemists (AOAC) and the American Public Health 
Association (APHA). Additionally; analytical methods are included that modify previously used 
methods to obtain lower detection limits, and/or to improve accuracy and precision. 
 
6.1 BIOLOGICAL MATERIALS 
 
Very limited data were found regarding the measurement of di-n-octylphthalate and its metabolites in 
biological fluids. Table 6-l summarizes the methods that are available. Analytical methods were 
located for measuring di-n-octylphthalate and its metabolites in urine, blood, and tissues (Albro and 
Moore 1974; Lanina et al. 1992; Oishi 1990). These methods include gas chromatography (GC) 
combined with mass spectrometry (MS) and high-performance liquid chromatography (HPLC) 
combined with an ultraviolet detector (UV). No comparisons can be made between methods since no 
data were given regarding sensitivity, recovery, or precision. 
 
6.2 ENVIRONMENTAL SAMPLES 
 
Table 6-2 summarizes the various methods available for measuring di-n-octylphthalate in 
environmental samples. GC/MS and GC combined with electron capture detection (ECD’) can be used 
to measure di-n-octylphthalate in water, waste water, groundwater, soil, and solid waste (APHA 1992; 
Eichelberger et al. 1983; EPA 1981, 1986a, 1986b, 1986c, 1990b; Furtmann 1994; Lopez-Avila et al. 
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Generally, sample preparation procedures involved extraction with methylene chloride at pH <2 and 
pH >11. The removal of interferents such as organochlorine pesticides and polychlorinated biphenyls 
has been approached though the addition of a clean-up step using Florisil columns (EPA 1981) and 
more recently solid-phase extraction alone with Florisil or other solid-phase matrices have been used 
(Furtmann 1994; Lopez-Avila et al. 1989; Ritsema et al. 1989). Sensitivity is in the low-ppb (µg/L) 
range for water samples using GC/MS (APHA 1992; Eichelberger et al. 1983; EPA 1986a, 1986b, 
1990b; Furtmann 1994; Valkenburg et al. 1989). GC/MS provided slightly better sensitivity than did 
GC/ECD. For water samples, recoveries are good for GC/MS and GC/ECD (Eichelberger et al. 1983; 
EPA 1981; Furtmann 1994; Ritsema et al. 1989; Valkenburg et al. 1989). Precision was adequate 
(<13-21% relative standard deviation [RSD]) (Eichelberger et al. 1983; Valkenburg et al. 1989). For 
soil and solid waste samples, sensitivity was in the ppm (µg/L) range using GC/MS and GC/ECD. For 
the standard analytical methods approved by EPA (Test Methods 1625, 8060, 8250, and 8270) and 
APHA, recovery and precision varied greatly for both water and soil samples (APHA 1992; EPA 
1986a, 1986b, 1986c, 1990b). 
 
6.3 ADEQUACY OF THE DATABASE 
 
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with 
the Administrator of EPA and agencies and programs of the Public Health Service) to assess whether 
adequate information on the health effects of di-n-octylphthalate is available. Where adequate 
information is not available, ATSDR, in conjunction with the NTP, is required to assure the initiation 
of a program of research designed to determine the health effects (and techniques for developing 
methods to determine such health effects) of di-n-octylphthalate. 
 
The following categories of possible data needs have been identified by a joint team of scientists from 
ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that if met would 
reduce the uncertainties of human health assessment. This definition should not be interpreted to mean 
that all data needs discussed in this section must be filled. In the future, the identified data needs will 
be evaluated and prioritized, and a substance-specific research agenda will be proposed. 
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6.3.1 Identification of Data Needs 
 
Methods for Determining Biomarkers of Exposure and Effect 
 
Exposure. Methods for Determining Parent Compounds and Degradation Products in Environmental 
Media.Methods are available for measuring di-n-octylphthalate and/or its metabolites (primarily the 
corresponding phthalate monoesters) in urine, blood, and tissues (Albro and Moore 1974; Lanina et al. 
1992; Oishi 1990); however, the data are very limited. More information on the accuracy, precision, 
and sensitivity of these methods is needed to evaluate the value of using the levels of di-n-octylphthalate 
and its metabolites (particularly in urine) as indicators of exposure. The lack of data for 
these methods makes it difficult to assess whether these methods are sufficiently sensitive to measure 
levels at which health effects might occur, as well as background levels in the population. 
 
Effect. No biomarkers of effects caused by di-n-octylphthalate have been identified in humans or 
animals, 
 
Methods for Determining Parent Compounds and Degradation Products in 
Environmental Media. Methods exist for measuring di-n-octylphthalate in water, groundwater, 
waste water, soil, and solid waste (APHA 1992; Eichelberger et al. 1983; EPA 1981, 1986a, 1986b, 
1986c, 1990b; Furtmann 1994; Lopez-Avila et al. 1989; Ritsema et al. 1989; Valkenburg et al. 1989); 
however, the database is limited. More information on the accuracy and precision of these methods is 
needed to accurately compare them. No data were located for measuring di-n-octylphthalate in air. 
The lack of data on background levels in the environment, as well as levels at which health effects 
might occur, prevents an evaluation of whether the methods are sensitive enough. Research 
investigating the relationship between environmental levels and observed health effects could increase 
confidence in existing methods and indicate where improvements are needed. Analytical methods are 
needed for determining degradation products in all environmental media. 
 
6.3.2 On-going Studies 
 
No on-going analytical methods studies were located. 
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7. REGULATIONS AND ADVISORIES 
 
 
The international, national, and state regulations and guidelines regarding di-n-octylphthalate in air, 
water, and other media are summarized in Table 7-l. 
 
ATSDR has derived an MRL of 3 mg/kg/day for acute-duration oral exposure in humans; this MRL is 
based on a LOAEL of 1,000 mg/kg/day in rats (Lake et al. 1986). 
 
ATSDR has derived an MRL of 0.4 mg/kg/day for intermediate-duration oral exposure in humans; this 
MRL is based on a NOAEL of 40.8 mg/kg/day in rats (Poon et al. 1995). 
 
An oral reference dose (RfD) is currently pending by EPA (IRIS 1995). 
 
Neither EPA or IARC has classified di-n-octylphthalate as to its carcinogenicity. 
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Acute Exposure -- Exposure to a chemical for a duration of 14 days or less, as specified in the 
Toxicological Profiles. 
 
Adsorption Coefficient (Koc) -- The ratio of the amount of a chemical adsorbed per unit weight of 
organic carbon in the soil or sediment to the concentration of the chemical in solution at equilibrium. 
 
Adsorption Ratio (Kd) -- The amount of a chemical adsorbed by a sediment or soil (i.e., the solid 
phase) divided by the amount of chemical in the solution phase, which is in equilibrium with the solid 
phase, at a fixed solid/solution ratio. It is generally expressed in micrograms of chemical sorbed per 
gram of soil or sediment. 
 
 
Bioconcentration Factor (BCF) -- The quotient of the concentration of a chemical in aquatic organisms 
at a specific time or during a discrete time period of exposure divided by the concentration in the 
surrounding water at the same time or during the same period. 
 
Cancer Effect Level (CEL) -- The lowest dose of chemical in a study, or group of studies, that 
produces significant increases in the incidence of cancer (or tumors) between the exposed population 
and its appropriate control. 
 
Carcinogen -- A chemical capable of inducing cancer. 
 
Ceiling Value -- A concentration of a substance that should not be exceeded, even instantaneously. 
 
Chronic Exposure -- Exposure to a chemical for 365 days or more, as specified in the Toxicological 
Profiles. 
 
Developmental Toxicity -- The occurrence of adverse effects on the developing organism that may 
result from exposure to a chemical prior to conception (either parent), during prenatal development, or 
postnatally to the time of sexual maturation. Adverse developmental effects may be detected at any 
point in the life span of the organism. 
 
Embryotoxicity and Fetotoxicity -- Any toxic effect on the conceptus as a result of prenatal exposure 
to a chemical; the distinguishing feature between the two terms is the stage of development during 
which the insult occurred. The terms, as used here, include malformations and variations, altered 
growth, and in utero death. 
 
EPA Health Advisory -- An estimate of acceptable drinking water levels for a chemical substance 
based on health effects information. A health advisory is not a legally enforceable federal standard, but 
serves as technical guidance to assist federal, state, and local officials. 
 
Immediately Dangerous to Life or Health (IDLH) -- The maximum environmental concentration of a 
contaminant from which one could escape within 30 min without any escape-impairing symptoms or 
irreversible health effects. 
 
Intermediate Exposure -- Exposure to a chemical for a duration of 15-364 days, as specified in the 
Toxicological Profiles. 





Immunologic Toxicity -- The occurrence of adverse effects on the immune system that may result from 
exposure to environmental agents such as chemicals. 
 
In vitro -- Isolated from the living organism and artificially maintained, as in a test tube. 
 
In Vivo -- Occurring within the living organism. 
 
Lethal Concentration(LO) (LC LO) -- The lowest concentration of a chemical in air which has been 
reported to have caused death in humans or animals. 
 
Lethal Concentration(50) (LC50) -- A calculated concentration of a chemical in air to which exposure for 
a specific length of time is expected to cause death in 50% of a defined experimental animal population. 
 
Lethal Dose(LO) ( LD LO) -- The lowest dose of a chemical introduced by a route other than inhalation 
that is expected to have caused death in humans or animals. 
 
Lethal Dose(50) (LD50) -- The dose of a chemical which has been calculated to cause death in 50% of a 
defined experimental animal population. 
 
Lethal Time(50) (LT50) -- A calculated period of time within which a specific concentration of a 
chemical is expected to cause death in 50% of a defined experimental animal population. 
 
Lowest-Observed-Adverse-Effect Level (LOAEL) -- The lowest dose of chemical in a study, or group 
of studies, that produces statistically or biologically significant increases in frequency or severity of 
adverse effects between the exposed population and its appropriate control. 
 
Malformations -- Permanent structural changes that may adversely affect survival, development, or 
function. 
 
Minimal Risk Level -- An estimate of daily human exposure to a dose of a chemical that is likely to be 
without an appreciable risk of adverse noncancerous effects over a specified duration of exposure. 
 
Mutagen -- A substance that causes mutations. A mutation is a change in the genetic material in a 
body cell. Mutations can lead to birth defects, miscarriages, or cancer. 
 
Neurotoxicity -- The occurrence of adverse effects on the nervous system following exposure to 
chemical. 
 
No-Observed-Adverse-Effect Level (NOAEL) -- The dose of chemical at which there were no 
statistically or biologically significant increases in frequency or severity of adverse effects seen between 
the exposed population and its appropriate control. Effects may be produced at this dose, but they are  
not considered to be adverse. 
 
Octanol-Water Partition Coefficient (Kow) -- The equilibrium ratio of the concentrations of a chemical 
in n-octanol and water, in dilute solution. 
 




q1 * -- The upper-bound estimate of the low-dose slope of the dose-response curve as determined by the
multistage procedure. The q1* can be used to calculate an estimate of carcinogenic potency, the
incremental excess cancer risk per unit of exposure (usually µg/L for water, mg/kg/day for food, and
µg/m3 for air).
Reference Dose (RfD) -- An estimate (with uncertainty spanning perhaps an order of magnitude) of the
daily exposure of the human population to a potential hazard that is likely to be without risk of
deleterious effects during a lifetime. The RfD is operationally derived from the NOAEL (from animal
and human studies) by a consistent application of uncertainty factors that reflect various types of data
used to estimate RfDs and an additional modifying factor, which is based on a professional judgment of
the entire database on the chemical. The RfDs are not applicable to nonthreshold effects such as cancer.
Reportable Quantity (RQ) -- The quantity of a hazardous substance that is considered reportable under
CERCLA. Reportable quantities are (1) 1 pound or greater or (2) for selected substances, an amount
established by regulation either under CERCLA or under Sect. 3 11 of the Clean Water Act. Quantities
are measured over a 24-hour period.
Reproductive Toxicity -- The occurrence of adverse effects on the reproductive system that may result
from exposure to a chemical. The toxicity may be directed to the reproductive organs and/or the related
endocrine system. The manifestation of such toxicity may be noted as alterations in sexual behavior,
fertility, pregnancy outcomes, or modifications in other functions that are dependent on the integrity of
this system.
Short-Term Exposure Limit (STEL) -- The maximum concentration to which workers can be exposed
for up to 15 min continually. No more than four excursions are allowed per day, and there must be at
least 60 min between exposure periods. The daily TLV-TWA may not be exceeded.
Target Organ Toxicity -- This term covers a broad range of adverse effects on target organs or
physiological systems (e.g., renal, cardiovascular) extending from those arising through a single limited
exposure to those assumed over a lifetime of exposure to a chemical.
Teratogen -- A chemical that causes structural defects that affect the development of an organism.
Threshold Limit Value (TLV) -- A concentration of a substance to which most workers can be
exposed without adverse effect. The TLV may be expressed as a TWA, as a STEL, or as a CL.
Time-Weighted Average (TWA) -- An allowable exposure concentration averaged over a normal
8-hour workday or 40-hour workweek.
Toxic Dose (TD50) -- A calculated dose of a chemical, introduced by a route other than inhalation,
which is expected to cause a specific toxic effect in 50% of a defined experimental animal population.
Uncertainty Factor (UF) -- A factor used in operationally deriving the RfD from experimental data.
UFs are intended to account for (1) the variation in sensitivity among the members of the human
population, (2) the uncertainty in extrapolating animal data to the case of human, (3) the uncertainty in
extrapolating from data obtained in a study that is of less than lifetime exposure, and (4) the uncertainty
in using LOAEL data rather than NOAEL data. Usually each of these factors is set equal to 10.






MINIMAL RISK LEVEL WORKSHEETS 
 
Chemical Name:  Di-n-octylphthalate 
CAS Number:  117-84-0 
Date:   December 1995 
Profile Status:  Post-Public Comment - Draft 3 
Route:   [  ] Inhalation [x] Oral 
Duration:   [x] Acute [ ] Intermediate [ ] Chronic 
Graph Key:   5 
Species :   Rat 
 
Minimal Risk Level:  3     [x] mg/kg/day [ ] ppm 
 
Reference:    Lake et al. 1986 
 
Experimental design:  Di-n-octylphthalate was administered (1,000 mg/kg/day) once/day for 14 days to 
a group of 4-6 male Sprague-Dawley rats. A group of male rats, administered the corn oil vehicle, 
served as controls. Following the last dose, animals were starved overnight and killed by cervical 
dislocation. Livers were excised to be weighed, then used for biochemical assays; histopathological 
examination was not performed. 
 
Effects noted in study and corresponding doses:   Liver effects were observed in treated rats. The 
hepatic effects consisted of a statistically significant (p < 0.01) increase (17 %) in relative liver weight 
and a reduction (approximately 30%) in 7-ethoxycoumarin O-deethylase activity relative to the vehicle 
control. Enzymatic indicators of peroxisome proliferation (KCN-insensitive palmitoyl-CoA oxidation 
or enoyl-CoA hydratase heat labile activity) were not significantly altered compared to controls. No 
significant changes in P-450 content or in the following activities were noted: ethylmorphine-N-
demethylase, lauric acid 1 1-hydroxylation, and lauric acid 12-hydroxylation. 
 
Dose and end point used for MRL derivation: 
 
[ ] NOAEL [x] LOAEL (DOSE: 1000 mg/kg/day) 
 
Uncertaintv Factors used in MRL derivation: 
 
[x]   3 for use of a minimal LOAEL 
[x]   10 for extrapolation from animals to humans 
[x]   10 for human variability 
 
Was a conversion used from ppm in food or water to a mg/body weight dose? No. If so, explain: 
 
If an inhalation study in animals. list the conversion factors used in determining human equivalent dose: 
 
Other additional studies or pertinent information which lend support to this MRL: The choice of liver 
toxicity as the basis for the acute oral MRL is supported by similar effects seen in other acute- and 
intermediate-duration studies in rats (DeAngelo et al. 1986; Lake et al. 1984; Mann et al. 1985). 





Chemical Name:  Di-n-octylphthalate 
CAS Number:   117-84-0 
Date:    December 1995 
Profile Status:   Post-Public Comment - Draft 3 
Route:    [ ] Inhalation [x] Oral 
Duration:   [ ] Acute [x] Intermediate [ ] Chronic 
Graph Key:   2 1 
Species:   Rat 
 
Minimal Risk Level:  0.4     [x]  mg/kg/day   [ ] ppm 
 
Reference:    Poon et al. 1995 
 
Experimental design:  Groups of 10 male and 10 female Sprague-Dawley rats were maintained on diets 
containing 0, 5, 50, 500, or 5,000 ppm di-n-octylphthalate (DNOP) in the diet for 13 weeks. The 
study authors determined that these dietary concentrations corresponded to doses of 0, 0.4, 3.5, 36.8, 
350.1 mg/kg/day (males) and 0, 0.4, 4.1, 40.8, 402.9 mg/kg/day (females). Control animals received 
feed containing 4% corn oil. The rats were examined daily for clinical signs of toxicity, while food 
consumption and body weight data were collected weekly. At the end of the study, the animals were 
anesthetized with an i.p. injection of pentobarbital. Blood was collected from the aortic artery for 
hematological and biochemical determinations; enzymatic activity assays and comprehensive 
histopathological examinations were performed (although only data on the liver, thyroid, testis, and 
epididymis were presented). 
 
Effects noted in study and corresponding doses:  No clinical signs of toxicity or reduction in food 
consumption or body weight gain were noted. No treatment-related changes in organ weights were 
noted. At 5,000 ppm, increased (p < 0.05) calcium was noted in males. Liver effects observed in rats 
administered di-n-octylphthalate in the diet at a concentration of 5,000 ppm; the study authors 
calculated the doses at this concentration to be 350.1 mg/kg/day (males) and 402.9 mg/kg/day (females) 
(Peon et al. 1995). The hepatic effects consisted of a significant (p < 0.05) increases in 
ethoxyresorufin-0-deethylase activity (12-fold, males; 3-fold, females); no significant changes were 
noted in liver aminopyrine-N-demethylase or aniline hydrolase activities. Also, at 5,000 ppm, 
histopathological changes in hepatic architecture were noted, including moderate accentuation of 
zonation and mild-to-moderate increases in perivenous cytoplasmic vacuolation. Mild histological 
changes in the thyroid were also noted at 5,000 ppm that consisted of reduction in the follicle size and 
decreased colloid density. No effects were observed at 500 ppm (36.8 mg/kg/day for males and 40.8 
mg/kg/day for females). The MRL was derived by dividing the NOAEL value of 40.8 mg/kg/day for 
hepatic effects by an uncertainty factor of 100 (10 for extrapolation from animals to humans and 10 for 
human variability). 
 
Dose and end point used for MRL derivation: 
 
[x] NOAEL  (DOSE:   40.8 mg/kg/day)          [ ] LOAEL 
 
Uncertainty Factors used in MRL derivation: 
 
[ ] 10 for use of a LOAEL 
[x] 10 for extrapolation from animals to humans 
[x] 10 for human variability 





Was a conversion used from ppm in food or water to a mg/body weight dose? No. 
If so, explain: 
 
If an inhalation study in animals, list the conversion factors used in determining human equivalent dose: 
 
Other additional studies or pertinent information which lend support to this MRL: The choice of liver 
toxicity as the basis of the MRL is supported by necrosis and mild hepatic fatty changes seen in other 
acute- and intermediate-duration studies in rats (DeAngelo et al. 1986; Lake et al. 1984, 1986; Mann et 
al. 1985). Thyroid toxicity (decreased thyroxine levels and ultrastructural changes) was observed after 
rats were fed 2,000 mg/kg/day of di-n-octylphthalate in the diet for 3, 10, or 21 days (Hinton et al. 
1986). 










Public Health Statement 
 
This chapter of the profile is a health effects summary written in non-technical language. Its intended 
audience is the general public especially people living in the vicinity of a hazardous waste site or 
chemical release. If the Public Health Statement were removed from the rest of the document, it would 
still communicate to the lay public essential information about the chemical. 
 
The major headings in the Public Health Statement are useful to find specific topics of concern. The 
topics are written in a question and answer format. The answer to each question includes a sentence 





Tables and Figures for Levels of Significant Exposure (LSE) 
 
A table (2-l) and figure (2-l) are used to summarize health effects and illustrate graphically levels of 
exposure associated with those effects. These levels cover health effects observed at increasing dose 
concentrations and durations, differences in response by species, minimal risk levels (MRLs) to humans 
for noncancer end points, and EPA’s estimated range associated with an upper- bound individual 
lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000. Use the LSE tables and figures for a quick 
review of the health effects and to locate data for a specific exposure scenario. The LSE tables and 
figures should always be used in conjunction with the text. All entries in these tables and figures 
represent studies that provide reliable, quantitative estimates of No-Observed-Adverse- Effect Levels 
(NOAELs), Lowest-Observed-Adverse-Effect Levels (LOAELs), or Cancer Effect Levels (CELs). 
 
The legends presented below demonstrate the application of these tables and figures. Representative 
examples of LSE Table 2-l and Figure 2-l are shown. The numbers in the left column of the legends 




See LSE Table 2-1 
 
(1)   Route of Exposure One of the first considerations when reviewing the toxicity of a substance 
using these tables and figures should be the relevant and appropriate route of exposure. When 
sufficient data exists, three LSE tables and two LSE figures are presented in the document. The 
three LSE tables present data on the three principal routes of exposure, i.e., inhalation, oral, and 
dermal (LSE Table 2-1, 2-2, and 2-3, respectively). LSE figures are limited to the inhalation (LSE 
Figure 2-l) and oral (LSE Figure 2-2) routes. Not all substances will have data on each route of 
exposure and will not therefore have all five of the tables and figures. 
 
(2)  Exposure Period Three exposure periods - acute (less than 15 days), intermediate (15-364 days), 
       and chronic (365 days or more) are presented within each relevant route of exposure. In this 




example, an inhalation study of intermediate exposure duration is reported. For quick reference to 
health effects occurring from a known length of exposure, locate the applicable exposure period 
within the LSE table and figure. 
 
(3)  Health Effect The major categories of health effects included in LSE tables and figures are death, 
systemic, immunological, neurological, developmental, reproductive, and cancer. NOAELs and 
LOAELs can be reported in the tables and figures for all effects but cancer. Systemic effects are 
further defined in the “System” column of the LSE table (see key number 18). 
 
(4)  Key to Figure Each key number in the LSE table links study information to one or more data 
points using the same key number in the corresponding LSE figure. In this example, the study 
represented by key number 18 has been used to derive a NOAEL and a Less Serious LOAEL 
(also see the 2  “18r” data points in Figure 2-l). 
 
(5)  Species The test species, whether animal or human, are identified in this column. Section 2.5, 
“Relevance to Public Health,” covers the relevance of animal data to human toxicity and Section 
2.3, “Toxicokinetics,” contains any available information on comparative toxicokinetics. Although 
NOAELs and LOAELs are species specific, the levels are extrapolated to equivalent human doses 
to derive an MRL. 
 
(6)  Exposure Frequency/Duration The duration of the study and the weekly and daily exposure 
regimen are provided in this column. This permits comparison of NOAELs and LOAELs from 
different studies. In this case (key number IS), rats were exposed to 1,1,2,2-tetrachloroethane via 
inhalation for 6 hours per day, 5 days per week, for 3 weeks. For a more complete review of the 
dosing regimen refer to the appropriate sections of the text or the original reference paper, i.e., 
Nitschke et al. 1981. 
 
(7)  System This column further defines the systemic effects. These systems include: respiratory, 
cardiovascular, gastrointestinal, hematological, musculoskeletal, hepatic, renal, and dermal/ocular. 
“Other” refers to any systemic effect (e.g., a decrease in body weight) not covered in these 
systems. In the example of key number 18, 1 systemic effect (respiratory) was investigated. 
 
(8)  NOAEL A No-Observed-Adverse-Effect Level (NOAEL) is the highest exposure level at which 
no harmful effects were seen in the organ system studied. Key number 18 reports a NOAEL of 3 
ppm for the respiratory system which was used to derive an intermediate exposure, inhalation 
MRL of 0.005 ppm (see footnote “b”). 
 
(9)  LOAEL A Lowest-Observed-Adverse-Effect Level (LOAEL) is the lowest dose used in the study 
that caused a harmful health effect. LOAELs have been classified into “Less Serious” and 
“Serious” effects. These distinctions help readers identify the levels of exposure at which adverse 
health effects first appear and the gradation of effects with increasing dose. A brief description of 
the specific endpoint used to quantify the adverse effect accompanies the LOAEL. The respiratory 
effect reported in key number 18 (hyperplasia) is a Less serious LOAEL of 10 ppm. MRLs are 
not derived from Serious LOAELs. 
 
(10) Reference The complete reference citation is given in chapter 8 of the profile. 
 
(11) CEL  A Cancer Effect Level (CEL) is the lowest exposure level associated with the onset of 
carcinogenesis in experimental or epidemiologic studies. CELs are always considered serious 





effects. The LSE tables and figures do not contain NOAELs for cancer, but the text may report 
doses not causing measurable cancer increases. 
 
(12) Footnotes Explanations of abbreviations or reference notes for data in the LSE tables are found in 
the footnotes. Footnote “b” indicates the NOAEL of 3 ppm in key number 18 was used to derive 




See Figure 2-1 
 
LSE figures graphically illustrate the data presented in the corresponding LSE tables. Figures help the 
reader quickly compare health effects according to exposure concentrations for particular exposure 
periods. 
 
(13) Exposure Period The same exposure periods appear as in the LSE table. In this example, health 
effects observed within the intermediate and chronic exposure periods are illustrated. 
 
(14) Health Effect These are the categories of health effects for which reliable quantitative data exists. 
The same health effects appear in the LSE table. 
 
(15) Levels of Exposure concentrations or doses for each health effect in the LSE tables are 
graphically displayed in the LSE figures. Exposure concentration or dose is measured on the log 
scale “y” axis. Inhalation exposure is reported in mg/m3 or ppm and oral exposure is reported in 
mg/kg/day. 
 
(16) NOAEL In this example, 1% NOAEL is the critical endpoint for which an intermediate inhalation 
exposure MRL is based. As you can see from the LSE figure key, the open-circle symbol 
indicates to a NOAEL for the test species-rat. The key number 18 corresponds to the entry in the 
LSE table. The dashed descending arrow indicates the extrapolation from the exposure level of 3 
ppm (see entry 18 in the Table) to the MRL of 0.005 ppm (see footnote “b” in the LSE table). 
 
(17) CEL  Key number 38r is 1 of 3 studies for which Cancer Effect Levels were derived. The 
diamond symbol refers to a Cancer Effect Level for the test species-mouse. The number 38 
corresponds to the entry in the LSE table. 
 
(18) Estimated Upper-Bound Human Cancer Risk Levels This is the range associated with the 
upper-bound for lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000. These risk levels are 
derived from the EPA’s Human Health Assessment Group’s upper-bound estimates of the slope of 
the cancer dose response curve at low dose levels (q1*). 
 
(19) Key to LSE Figure The Key explains the abbreviations and symbols used in the figure. 







Chapter 2 (Section 2.5) 
 
Relevance to Public Health 
 
The Relevance to Public Health section provides a health effects summary based on evaluations of 
existing toxicologic, epidemiologic, and toxicokinetic information. This summary is designed to present 
interpretive, weight-of-evidence discussions for human health end points by addressing the following 
questions. 
 
1. What effects are known to occur in humans? 
 
2. What effects observed in animals are likely to be of concern to humans? 
 
3. What exposure conditions are likely to be of concern to humans, especially around hazardous 
    waste sites? 
 
The section covers end points in the same order they appear within the Discussion of Health Effects by 
Route of Exposure section, by route (inhalation, oral, dermal) and within route by effect. Human data 
are presented first, then animal data. Both are organized by duration (acute, intermediate, chronic). In 
vitro data and data from parenteral routes (intramuscular, intravenous, subcutaneous, etc.) are also 
considered in this section. If data are located in the scientific literature, a table of genotoxicity 
information is included. 
 
The carcinogenic potential of the profiled substance is qualitatively evaluated, when appropriate, using 
existing toxicokinetic, genotoxic, and carcinogenic data. ATSDR does not currently assess cancer 
potency or perform cancer risk assessments. Minimal risk levels (MRLs) for noncancer end points (if 
derived) and the end points from which they were derived are indicated and discussed. 
 
Limitations to existing scientific literature that prevent a satisfactory evaluation of the relevance to 
public health are identified in the Data Needs section. 
 
Interpretation of Minimal Risk Levels 
 
Where sufficient toxicologic information is available, we have derived minimal risk levels (MRLs) for 
inhalation and oral routes of entry at each duration of exposure (acute, intermediate, and chronic). 
These MRLs are not meant to support regulatory action; but to acquaint health professionals with 
exposure levels at which adverse health effects are not expected to occur in humans. They should help 
physicians and public health officials determine the safety of a community living near a chemical 
emission, given the concentration of a contaminant in air or the estimated daily dose in water. MRLs 
are based largely on toxicological studies in animals and on reports of human occupational exposure. 
 
MRL users should be familiar with the toxicologic information on which the number is based. Chapter 
2.5, “Relevance to Public Health,” contains basic information known about the substance. Other 
sections such as 2.7, “Interactions with Other Substances,” and 2.8, “Populations that are Unusually 
Susceptible” provide important supplemental information. 
 
MRL users should also understand the MRL derivation methodology. MRLs are derived using a 
modified version of the risk assessment methodology the Environmental Protection Agency (EPA) 
provides (Barnes and Dourson 1988) to determine reference doses for lifetime exposure (RfDs). 





To derive an MRL, ATSDR generally selects the most sensitive endpoint which, in its best judgement, 
represents the most sensitive human health effect for a given exposure route and duration. ATSDR 
cannot make this judgement or derive an MRL unless information (quantitative or qualitative) is 
available for all potential systemic, neurological, and developmental effects. If this information and 
reliable quantitative data on the chosen endpoint are available, ATSDR derives an MRL using the most 
sensitive species (when information from multiple species is available) with the highest NOAEL that 
does not exceed any adverse effect levels. When a NOAEL is not available, a lowest-observed-adverse- 
effect level (LOAEL) can be used to derive an MRL, and an uncertainty factor (UF) of 10 must be 
employed. Additional uncertainty factors of 10 must be used both for human variability to protect 
sensitive subpopulations (people who are most susceptible to the health effects caused by the substance) 
and for interspecies variability (extrapolation from animals to humans). In deriving an MRL, these 
individual uncertainty factors are multiplied together. The product is then divided into the inhalation 
concentration or oral dosage selected from the study. Uncertainty factors used in developing a 
substance-specific MRL are provided in the footnotes of the LSE Tables. 




 
